{"id":5153,"date":"2026-07-01T21:43:33","date_gmt":"2026-07-01T21:43:33","guid":{"rendered":"https:\/\/oshot.info\/members\/?p=5153"},"modified":"2026-07-01T21:43:33","modified_gmt":"2026-07-01T21:43:33","slug":"jcpm2026-06-23-female-ejaculation-clitoxin-priapus-toxin-alopecia","status":"publish","type":"post","link":"https:\/\/oshot.info\/members\/jcpm2026-06-23-female-ejaculation-clitoxin-priapus-toxin-alopecia\/","title":{"rendered":"JCPM2026.06.23 | Female Ejaculation | Clitoxin\u00ae | Priapus Toxin\u00ae | Alopecia"},"content":{"rendered":"<style>#jcpm-post{max-width:100%;box-sizing:border-box;overflow-x:hidden;font-size:1.08em;line-height:1.55;overflow-wrap:break-word;word-wrap:break-word;}#jcpm-post *{max-width:100%;box-sizing:border-box;}#jcpm-post img{max-width:100%;height:auto;}#jcpm-post table{width:100%;border-collapse:collapse;table-layout:fixed;}#jcpm-post h1{line-height:1.2;}#jcpm-post a{color:#0563C1;overflow-wrap:break-word;word-break:break-word;}#jcpm-post ul,#jcpm-post ol{padding-left:1.4em;}@media (max-width:600px){#jcpm-post{font-size:1em;}#jcpm-post td{display:block;width:100%!important;box-sizing:border-box;}#jcpm-post td+td{margin-top:4px;}}<\/style>\n<div id=\"jcpm-post\" style=\"max-width: 100%; box-sizing: border-box; overflow-x: hidden; font-size: 1.08em; line-height: 1.55;\">\n<div title=\"header\">\n<table style=\"width: 100%; border-collapse: collapse;\" width=\"100%\" cellspacing=\"0\" cellpadding=\"7\">\n<tbody>\n<tr>\n<td style=\"border: none; padding: 0in;\" valign=\"top\" width=\"100%\">\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.1in; direction: ltr; background: transparent;\" align=\"left\"><span style=\"color: #808080;\">Journal Club with Pearls &amp; Marketing 2026.06.23 <\/span><span style=\"color: #0563c1;\"><u><a href=\"https:\/\/cellularmedicineassociation.org\/\">Cellular Medicine Association<\/a><\/u><\/span><\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.46in; direction: ltr; background: transparent;\" align=\"left\">\n<\/div>\n<p style=\"line-height: 100%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.21in; direction: ltr; background: transparent; letter-spacing: 0.3pt; border-top: none; border-bottom: 1pt solid #B35F06; border-left: none; border-right: none; padding: 0 0 0.06in 0;\" align=\"left\"><span style=\"color: #252525;\"><span style=\"font-family: Impact, serif;\"><span style=\"font-size: xx-large;\">JCPM2026.06.23<\/span><\/span><\/span><\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; margin-top: 0.06in;\" align=\"left\"><span style=\"color: #000000;\"><span style=\"font-family: Calibri, serif;\">The following is an edited transcript of the <\/span><\/span><span style=\"color: #000000;\"><span style=\"font-family: Calibri, serif;\"><i>Journal Club with Pearls &amp; Marketing<\/i><\/span><\/span><span style=\"color: #000000;\"><span style=\"font-family: Calibri, serif;\"> (JCPM) of June 23, 2026, with Charles Runels, MD. <\/span><\/span><\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; margin-top: 0.06in;\" align=\"left\"><span style=\"color: #0563c1;\"><u><a href=\"https:\/\/cellularmedicineassociation.org\/wp-content\/uploads\/2026\/07\/JCPM2026.06.23-final.pdf\" target=\"_blank\" rel=\"noopener\"><span style=\"font-family: Calibri, serif;\">&gt;-&gt; The PDF of this live journal club can be seen here &lt;-&lt;<\/span><\/a><\/u><\/span><\/p>\n<div style=\"padding: 56.25% 0 0 0; position: relative;\"><iframe style=\"position: absolute; top: 0; left: 0; width: 100%; height: 100%;\" title=\"JCPM2026.06.23 | Female Ejaculation | Clitoxin\u00ae | Priapus Toxin\u00ae | Alopecia\" src=\"https:\/\/player.vimeo.com\/video\/1206135470?badge=0&amp;autopause=0&amp;player_id=0&amp;app_id=58479\" frameborder=\"0\"><\/iframe><\/div>\n<p><script src=\"https:\/\/player.vimeo.com\/api\/player.js\"><\/script><\/p>\n<h1 style=\"color: #b35f06; line-height: 115%; text-align: left; page-break-inside: avoid; orphans: 2; widows: 2; margin-top: 0.33in; margin-bottom: 0; direction: ltr; background: transparent; page-break-after: avoid; font-weight: bold;\" align=\"left\">Topics Covered<\/h1>\n<ul>\n<li>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">PRP in Dermatology: Single-Spin, Double-Spin, and How to Deliver It<\/p>\n<\/li>\n<li>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">Shockwave Combined with PRP for ED and Interstitial Cystitis<\/p>\n<\/li>\n<li>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">Answering a Critical Review: Why Saline Is Not a Placebo<\/p>\n<\/li>\n<li>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">A Question About the O-Shot<sup style=\"vertical-align: super; font-size: 0.9em; font-weight: bold; line-height: 0;\">\u00ae<\/sup>, Clitoxin<sup style=\"vertical-align: super; font-size: 0.9em; font-weight: bold; line-height: 0;\">\u00ae<\/sup>, and Female Ejaculation<\/p>\n<\/li>\n<li>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">What Female Ejaculation Is: The Role of the Skene's Glands<\/p>\n<\/li>\n<li>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">Why the O-Shot<sup style=\"vertical-align: super; font-size: 0.9em; font-weight: bold; line-height: 0;\">\u00ae<\/sup> Injection Site Matters<\/p>\n<\/li>\n<li>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">How Clitoxin<sup style=\"vertical-align: super; font-size: 0.9em; font-weight: bold; line-height: 0;\">\u00ae<\/sup> Fits with Female Ejaculation<\/p>\n<\/li>\n<li>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">The Emotional and Spiritual Dimension of Orgasm<\/p>\n<\/li>\n<li>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">Botulinum Toxin Dosing with Clitoxin\u00ae: 50 Versus 100 Units<\/p>\n<\/li>\n<li>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">Financing Research Through Membership<\/p>\n<\/li>\n<\/ul>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; margin-top: 0.06in;\" align=\"left\"><a href=\"https:\/\/runels.com\/\"> <img decoding=\"async\" style=\"display: block; max-width: 210px; width: 100%; height: auto; margin: 1.1em auto; border-radius: 6px;\" src=\"data:image\/jpeg;base64,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\" alt=\"\" \/> <\/a><\/p>\n<p style=\"line-height: 100%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\"><span style=\"color: #b35f06;\"><span style=\"font-size: small;\"><b>Charles Runels, MD<br \/>\nAuthor, researcher, and inventor of the Vampire Facelift\u00ae, Orchid Shot\u00ae (O-Shot\u00ae), Priapus Shot\u00ae (P-Shot\u00ae), Priapus Toxin\u00ae, Vampire Breast Lift\u00ae, and Vampire Wing Lift\u00ae, &amp; Clitoxin\u00ae procedures.<\/b><\/span><\/span><\/p>\n<p style=\"line-height: 100%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.21in; direction: ltr; background: transparent; letter-spacing: 0.3pt; border-top: none; border-bottom: 1pt solid #B35F06; border-left: none; border-right: none; padding: 0 0 0.06in 0;\" align=\"left\"><span style=\"color: #252525;\"><span style=\"font-family: Impact, serif;\"><span style=\"font-size: xx-large;\">Transcript<\/span><\/span><\/span><\/p>\n<h1 style=\"color: #b35f06; line-height: 115%; text-align: left; page-break-inside: avoid; orphans: 2; widows: 2; margin-top: 0.33in; margin-bottom: 0; direction: ltr; background: transparent; page-break-after: avoid; font-weight: bold;\" align=\"left\">Introduction<\/h1>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">Today I'll answer a question I get periodically. I don't think I've covered it on a Journal Club in years, if at all \u2014 regarding <i><b>female ejaculation and how it might relate to our O-Shot<\/b><\/i><sup style=\"vertical-align: super; font-size: 0.9em; font-weight: bold; line-height: 0;\"><i><b>\u00ae<\/b><\/i><\/sup><i><b> procedure<\/b><\/i>. Before I get to that, which will involve a number of diagrams and papers, let me cover two or three articles that came out in the past week that I think you might find helpful.<\/p>\n<h1 style=\"color: #b35f06; line-height: 115%; text-align: left; page-break-inside: avoid; orphans: 2; widows: 2; margin-top: 0.33in; margin-bottom: 0; direction: ltr; background: transparent; page-break-after: avoid; font-weight: bold;\" align=\"left\">PRP in Dermatology: Single-Spin, Double-Spin, and How to Deliver It<\/h1>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">The first one is about platelet-rich plasma and devices for platelet-rich plasma in dermatology.<a style=\"font-size: 57%;\" href=\"#sdfootnote1sym\" name=\"sdfootnote1anc\"><sup style=\"vertical-align: super; font-size: 0.9em; font-weight: bold; line-height: 0;\">1<\/sup><\/a><\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">They're not covering our sexual indications or urology, just dermatology, which would include alopecia. They start with a nice overview of what PRP is, which is useful for those of you who may be new. And then they give something that I think will surprise some of you.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">I've seen two studies showing that, with alopecia, a single spin is actually superior to a double spin. That's surprising to many of you. I've always said I think this research is very strong in orthopedics \u2014 that you really need a double spin to achieve around 5 times the concentration of whole blood for optimal results.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">But with our procedures, the answer to that is no one really knows. The research is starting to accumulate some. I've added a link to your resources for all the references I'm about to talk with you about. I had to purchase some of them, so I try to be respectful of that, but I'll show you the main things I think were helpful. More and more, research is backing up the idea that it might really be better to use a single spin when treating alopecia.<a style=\"font-size: 57%;\" href=\"#sdfootnote2sym\" name=\"sdfootnote2anc\"><sup style=\"vertical-align: super; font-size: 0.9em; font-weight: bold; line-height: 0;\">2<\/sup><\/a><\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">And then, after you have the PRP prepared, how do you deliver it to the skin?<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">They talk about derma rollers.<a style=\"font-size: 57%;\" href=\"#sdfootnote3sym\" name=\"sdfootnote3anc\"><sup style=\"vertical-align: super; font-size: 0.9em; font-weight: bold; line-height: 0;\">3<\/sup><\/a><\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">Sixteen years ago, when I first started working with PRP, these were common. I found them more painful, but they're still in some studies and still work. If you just physically consider it, it's difficult to do the same number of puncture wounds. If you have a device that does \u2014 if you do the math on it, the RPMs and the number of needles \u2014 you can have thousands of microneedle puncture wounds per minute, where with a rolling device, not so much. And if you think about the mechanics of a rolling device, it can be more of a tearing versus a very quick in-and-out.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">So I think most of us have decided that the roller device might be okay, but the pens work better. And then the lesson that was learned several years ago is that you definitely want a pen that's FDA-cleared for this purpose, or else <span style=\"color: #0563c1;\"><u><a href=\"https:\/\/www.rollingstone.com\/culture\/culture-news\/vampire-facials-hiv-new-mexico-risks-benefits-829686\/\">you can cross-contaminate and transfer pathogens from one patient to the next.<\/a><\/u><\/span><a style=\"font-size: 57%;\" href=\"#sdfootnote4sym\" name=\"sdfootnote4anc\"><sup style=\"vertical-align: super; font-size: 0.9em; font-weight: bold; line-height: 0;\">4<\/sup><\/a><\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">=&gt;<a href=\"https:\/\/cellularmedicineassociation.org\/procedures\/\"><span style=\"color: #0563c1;\"><u><span style=\"color: #c00000;\"> Apply for <\/span><\/u><\/span><span style=\"color: #0563c1;\"><u><span style=\"color: #c00000;\"><i>Online Training for Multiple PRP Procedures<\/i><\/span><\/u><\/span><\/a> &lt;=<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">So it's imperative. Anything else you're doing is truly criminal, and two people are in prison for breaking that rule and transmitting HIV.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">Done the right way, we handle blood all the time, but we have to keep reminding ourselves that it can't just be, quote, \"a provider\" who turns out to be someone who's great at makeup and nails but really doesn't have the qualifications to do what we do.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">I saw a recent article the AMA put out recommending that we say what we are \u2014 whether we're doctors, physician extenders, nurse practitioners, RNs, or whatever we are \u2014 instead of using a \"provider\" word that can be confusing. I was talking with one of my sons about his visit to, quote, \"the doctor\" in New York City. He's still not sure what the qualifications of the person who took care of him are. As you know, there can be some blurring in how people introduce themselves.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">So, back to this. For those with proper training, this is as safe as anything we do, and safer than almost everything we do. Any skin type \u2014 we handle blood all the time. We break the rules, and horrible things can happen. So if you're using one of these rollers, it works not as well, I don't think \u2014 and I think just the math of it shows that \u2014 as doing the pens.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">And then there's just injecting subdermal, intradermal. Even though the research shows that for alopecia, the single spin with microneedling works best, sometimes you have an area that's thin, but there's still enough hair there that it's difficult to make the rim surface of your pen flush with the skin, so your delivery of the puncture wounds is inconsistent and unreliable. So in those areas especially, I like to inject intradermally about a centimeter apart, about 0.1 cc of PRP per injection.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">But it's not like dosing some dangerous drug. You have to kind of get a feel for it, or it takes too long. If you're watching the plunger and doing each injection trying to accurately measure that much, you'll torment the patient, because it takes too long.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">They also talk about <i><b>mesotherapy guns<\/b><\/i>. I see this more in people from other countries, though some in this country have them. I think they're more commonly used in Europe. We had a physician from Canada in <span style=\"color: #0563c1;\"><u><a href=\"https:\/\/cellularmedicineassociation.org\/prp-training-runels\/\">our recent hands-on workshop<\/a><\/u><\/span>, and she uses this a lot. They're fast, so you can do intradermal injections very quickly at an exact depth. Instead of microneedling and then having it absorbed through the insult to the surface, you actually have an injection with each one of those rapid insertions of the needle.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">A<a href=\"https:\/\/botoxclass.com\/\"> <img decoding=\"async\" style=\"display: block; max-width: 320px; width: 100%; height: auto; margin: 1.1em auto;\" src=\"data:image\/jpeg;base64,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\" alt=\"\" \/> <\/a> nd I know there are some who are using other devices where it's absorbed by a jet of air. I know these are catching on in some places. My worry is that, somehow, the trauma of passing through the skin might denature some of those small peptides. Just like if you've reconstituted growth hormone \u2014 Saizen or Genotropin \u2014 ever, you can't agitate the vial. You put the saline or the water in, and you gently swirl it. If you shake it, you tear apart the amino acid chain; it's denatured, you lose the code, and it's no longer of use.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">Many of the peptides that are in platelets have that same nature, so I worry about blasting it through.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">Some even try to argue that just passing it through a small needle \u2014 or pulling platelets from the venipuncture through a small needle \u2014 activates them. They insist that you should use a 17- or 18-gauge needle to do your phlebotomy, or else you're activating the platelets. No one's really sure of the answer. But I think that, considering the size of a platelet, a 30-gauge, or a 21-gauge butterfly, is still pretty small. Blasting it sonically through the skin, though, would be obvious disruption. So that was just my take, until the research is done. I can see we're trying to get away from needles, but I worry about the needleless delivery systems. Someone should do the study and compare them.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">The <span style=\"color: #0563c1;\"><u><a href=\"https:\/\/www.amazon.com\/Pain-Care-Labs-Personal-Vibrating\/dp\/B00HQ1LJHO\/ref=sr_1_5_sspa?crid=NBYJ3HKHOOE0&amp;dib=eyJ2IjoiMSJ9.iKS6OxRGFUMmGZKZAHcmMVkOc-gCOyEcxxMm13ymX9JDyVlgDvehAtjsKN_tuPtzoSfk-sDrkFu8nHDuqkGXDG0eXbau0TM7o0rGjmgbqOHUOyJeXn5k56_jrWtLvd-jl1pf7IbhoH6KmTdxGH2cfY4qGgKTZxlOAkhsSz_hcqnwZnhzOThLQl9SrtoqMWP1BQ576-02bBghBGcximjNCpB_Olzg8L3FP2_R3iPfp_bIuWq7VW0D45cLrMWpA-noYnimPCpMLKk9w2WA1O8zO4vSM2OimHyWAb7yES0OPIc.cUH-UW5xrGI--rBunD-TpMDcMcJuv-qzBzEwS7_gzY0&amp;dib_tag=se&amp;keywords=vibration%2Bdevice%2Bfor%2Bpain&amp;qid=1782937720&amp;sprefix=vibration%2Bdevice%2Bfor%2Bpain%2Caps%2C162&amp;sr=8-5-spons&amp;sp_csd=d2lkZ2V0TmFtZT1zcF9hdGY&amp;th=1\"><i><b>vibrating devices<\/b><\/i><\/a><\/u><\/span> \u2014 these are more for pain, and they actually work well. You can buy those from Amazon \u2014 just a little vibrating thing that you put against the skin while you're doing the injection. If you learn how to do it the way I teach it on our membership site, you really don't need much in the way of pain relief, because you'll be done in less than a minute, literally, without rushing. When I treat the scalp, it's usually 30 to 45 seconds, depending on how much scalp I'm treating, without rushing. So if it's taking a long time, obviously, there's more prolonged pain, which leads to less tolerance. Anyway, the vibrating device is great.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">And if you're doing a hair transplant, of course, it's a different game. But just injecting or microneedling it shouldn't be a long thing. I do use this a lot \u2014 the cooling \u2014 just an ice pack, just regular ice put in a Ziploc bag. And I precede the treatment usually with 30% lidocaine ointment. BLT, if you have it, is okay, but I use the ointment when I do the O-Shots<sup style=\"vertical-align: super; font-size: 0.9em; font-weight: bold; line-height: 0;\">\u00ae<\/sup>. I've started using it on the scalp. It's too strong to use if you had, say, the back, or a large surface \u2014 legs \u2014 where you're trying to do hair removal. But for our procedures, where the surface area is small, 30% lidocaine ointment works great.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">Nerve blocks \u2014 I think that's more for... I used to do it. I teach how to do it. There are videos on our website about how to do it, including one by a hair transplant surgeon. Of course, as an ER doctor, I did it routinely. But by the time you're through with your nerve block \u2014 actually, before you're through with it \u2014 I will be finished treating the person's scalp. So I quit doing that so much.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">Let's see, what else do I want to say about this? It's a nice article that reviews some basic ideas, and those were the main points I wanted to take away from it. I'll come back to that when we talk about female ejaculation.<\/p>\n<h1 style=\"color: #b35f06; line-height: 115%; text-align: left; page-break-inside: avoid; orphans: 2; widows: 2; margin-top: 0.33in; margin-bottom: 0; direction: ltr; background: transparent; page-break-after: avoid; font-weight: bold;\" align=\"left\">Shockwave Combined with PRP for ED and Interstitial Cystitis<\/h1>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">This next one was interesting. We're starting to see more and more about shockwave combined with our PRP procedures. Some of you are in the GAINSWave group, which is an excellent protocol. Others of you are using other protocols, with great results. And now we have multiple studies showing that if you're using shockwave for ED, you'll get much better results when you combine it with our P-Shot<sup style=\"vertical-align: super; font-size: 0.9em; font-weight: bold; line-height: 0;\">\u00ae<\/sup> procedure.<a style=\"font-size: 57%;\" href=\"#sdfootnote5sym\" name=\"sdfootnote5anc\"><sup style=\"vertical-align: super; font-size: 0.9em; font-weight: bold; line-height: 0;\">5<\/sup><\/a><\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">There are also multiple studies now showing that for interstitial cystitis, using PRP can help with the pain.<a style=\"font-size: 57%;\" href=\"#sdfootnote6sym\" name=\"sdfootnote6anc\"><sup style=\"vertical-align: super; font-size: 0.9em; font-weight: bold; line-height: 0;\">6<\/sup><\/a> The studies I've seen have involved injecting directly into the bladder. Of course, many of us are seeing great results just injecting with our basic <a href=\"https:\/\/oshot.info\/\"><span style=\"color: #0563c1;\"><u>O-Shot<\/u><\/span><span style=\"color: #0563c1;\"><u><sup style=\"vertical-align: super; font-size: 0.9em; font-weight: bold; line-height: 0;\">\u00ae<\/sup><\/u><\/span><span style=\"color: #0563c1;\"><u> procedure<\/u><\/span><\/a>. But in this study, they used shockwave with PRP and showed some synergistic effects.<a style=\"font-size: 57%;\" href=\"#sdfootnote7sym\" name=\"sdfootnote7anc\"><sup style=\"vertical-align: super; font-size: 0.9em; font-weight: bold; line-height: 0;\">7<\/sup><\/a><\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">Great article, especially for those of you who have Shockwave in your office.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">We have amazing results just with our basic O-Shot<sup style=\"vertical-align: super; font-size: 0.9em; font-weight: bold; line-height: 0;\">\u00ae<\/sup>, but if you have the shockwave, and it's been shown to improve results, why not? This is so ripe for some of you to study, because I've been hearing about it from our providers for over a decade now. I think it needs a good study from a urologist who maybe can do both methods and compare the two with a crossover. I think you'll find our O-Shot<sup style=\"vertical-align: super; font-size: 0.9em; font-weight: bold; line-height: 0;\">\u00ae<\/sup> is as effective with a lot less drama, since you don't have to inject into the bladder.<\/p>\n<h1 style=\"color: #b35f06; line-height: 115%; text-align: left; page-break-inside: avoid; orphans: 2; widows: 2; margin-top: 0.33in; margin-bottom: 0; direction: ltr; background: transparent; page-break-after: avoid; font-weight: bold;\" align=\"left\">Answering a Critical Review: Why Saline Is Not a Placebo<\/h1>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">This next one, I think, is worth looking at.<a style=\"font-size: 57%;\" href=\"#sdfootnote8sym\" name=\"sdfootnote8anc\"><sup style=\"vertical-align: super; font-size: 0.9em; font-weight: bold; line-height: 0;\">8<\/sup><\/a> I found it to be very biased, but that doesn't mean we don't look at it. We want to see our most critical, our smartest critics \u2014 we need them to keep us smart. You should welcome an enemy, of course, metaphorically. We're at war. It's an intellectual war, and we should seek disagreement to help our thinking. So I want to show you where someone disagrees with what we're doing, and give you my reasons why I think they're seeing part of the picture, so that you have an awareness of every side of what's happening in the debate, or the conversation.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">I like to think there's been a scientific conversation going on since somebody figured out how to make a fire or make a wheel. When we jump in and do something, if we're not aware of the conversation that came before, and in the other rooms \u2014 as in other countries or other specialties \u2014 we can come across looking ill-informed at best, and at worst, we can almost be like a child who just jumped into a grown-up's conversation.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">And part of the basic idea \u2014 I know you know it, but I'm saying it so it can be front of mind as we talk about what it takes to prove something, or not prove it, or support it, or not support it. The basic premise of science is not that we prove things, but that we present a hypothesis, and then we try to disprove it, and it stands until someone disproves it.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">So, with that in mind, let's look at the main criticism of this paper when they get to discussing adult dysfunction. They quote the paper they use, which says, \"Randomized evidence is mixed. In the prospective double-blind placebo-controlled trial by Masterson...\"<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">And this is the one \u2014 it's the only one they really have to wave around showing negative results.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">You can say that a later randomized placebo-controlled trial reported benefit. It wasn't just later \u2014 it was prior to that as well. We have at least four double-blind placebo-controlled studies showing benefit.<a style=\"font-size: 57%;\" href=\"#sdfootnote9sym\" name=\"sdfootnote9anc\"><sup style=\"vertical-align: super; font-size: 0.9em; font-weight: bold; line-height: 0;\">9<\/sup><\/a> So both before and after that, they showed benefit. And what they don't mention about this Masterson study is that they used half the volume that we use. They did not activate the PRP with anything \u2014 calcium chloride or anything like that. Some of you use thrombin or calcium gluconate.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\"><span style=\"color: #0563c1;\"><u><a href=\"https:\/\/accma.memberlodge.org\/page-925782\">=&gt;Next Hands-On Workshops with Live Models&lt;=<\/a><\/u><\/span><\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">It was unclear to me what they did. They asked the people not to stop their PDE5 inhibitors, but I can't see where they documented what actually happened with that. And of course, they don't bring up the fact \u2014 and it is a fact \u2014 that saline in a soft-tissue study is not a placebo. We have multiple review articles in dermatology about various uses of saline. When you diffuse it into soft tissue, you're having a mechanical effect that has been widely and repeatedly shown to help with scarring, leishmaniasis, even some osteoarthritis of the knee. So you're not doing nothing.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">And in this Masterson study, both the placebo arm and the PRP arm showed benefit, even though it was half the dose without activation.<a style=\"font-size: 57%;\" href=\"#sdfootnote10sym\" name=\"sdfootnote10anc\"><sup style=\"vertical-align: super; font-size: 0.9em; font-weight: bold; line-height: 0;\">10<\/sup><\/a> Both of them were statistically significant in their improvement of erectile function. And PRP beat the placebo arm, but not in a statistically significant way, when it was done at half dose without activation.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">So <i><b>what they really did was compare two treatments<\/b><\/i> [even though they called one are a placebo arm].<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">I don't see this talked about in the urology literature. It is talked about in the dermatology literature. So this is one of those examples where conversations are happening, but those standing in one room are unaware of what's being said in another room.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">The most dramatic example of this happened while I was in medical school. You had gynecologists routinely doing endoscopic surgery \u2014 partially, and probably mostly, introduced initially by one of the gynecologists in our group, Dr. Michael Goodman. So he introduced it, it's being done, but it took another gynecologist to see that, oh, this might work for cholecystectomy. So you had a number of years \u2014 not weeks or months, years \u2014 where gynecologists were routinely doing endoscopic surgery and the general surgeons were not. There were two different conversations happening.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">And much of what I was lucky enough to come up with really was that. It was just listening in the other rooms and bringing it over here. I listened to what the dentists and orthopedic surgeons were doing and brought it into urogynecology and urology and dermatology.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">So, back to this criticism. If this is the best they've got, then we're actually in pretty good standing, because they also mentioned meta-analyses, and two showed benefit. Short-term is debatable, but really, if you have to repeat something every year or every year and a half, that's not so bad.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">And the other thing that's not mentioned is that all of the other alternatives are not addressing the pathophysiology. In other words, <i><b>you can take PDE5 inhibitors every day, but you're not slowing down, or even possibly reversing, the neurovascular problems that might be causing the problem. Yet we have hundreds \u2014 actually thousands \u2014 of papers showing that platelet-rich plasma can trigger neovascularization and neurogenesis,<\/b><\/i> which does not happen with the other alternatives.<a style=\"font-size: 57%;\" href=\"#sdfootnote11sym\" name=\"sdfootnote11anc\"><sup style=\"vertical-align: super; font-size: 0.9em; font-weight: bold; line-height: 0;\">11<\/sup><\/a>,<a style=\"font-size: 57%;\" href=\"#sdfootnote12sym\" name=\"sdfootnote12anc\"><sup style=\"vertical-align: super; font-size: 0.9em; font-weight: bold; line-height: 0;\">12<\/sup><\/a><\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">So the idea that we shouldn't be offering it... I'm not saying it's proven \u2014 again, you don't prove anything \u2014 but when you have literally thousands of papers that show benefit, and you have this one double-blind placebo-controlled study that I think was poorly designed and didn't recognize that its placebo was not a placebo, I'm going to disagree. They're saying it's not far enough along to do it. But I think if it's my penis, or the penis of others who are informed, that's the deal.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">You have to have an informed consent that says, \"This is not standard. Your insurance isn't paying for it. There are people who say it needs more research, but I think it might help, and if it doesn't, I'm not keeping your money.\"<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">We have a very strong consent form \u2014 so get your attorney to look at it \u2014 but I think informed consent is the foundation.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">And now we have a decade and a half of real-world data, which is not nothing. If this were just ripping people off, it'd be all over the internet. The world's too small. The internet is too informative if we were stealing from people. I know that's not a study, but it's not nothing \u2014 and actually, the FDA is starting to pay more attention to that, to help things move along.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">As far as when they review these articles about Peyronie's disease \u2014 the same thing. They don't really even mention the main man, the legend who came up with the idea. I guess I shouldn't say that, it sounds disrespectful, but I love the guy \u2014 the guy who came up with the idea of injecting a vasoactive substance into the penis, from which we now have Caverject and Trimix and all that. He did a study in 2017 \u2014 so, 9 years ago \u2014 showing that Xiaflex was inferior to PRP for Peyronie's disease.<a style=\"font-size: 57%;\" href=\"#sdfootnote13sym\" name=\"sdfootnote13anc\"><sup style=\"vertical-align: super; font-size: 0.9em; font-weight: bold; line-height: 0;\">13<\/sup><\/a> It's usually not even mentioned, even though this guy is a legend in the field: Ronald Virag.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">So I think, looking at our critics \u2014 it's worth knowing and thinking about, and you use it to motivate you to do more critical thinking. And you don't argue; you just keep putting out the good stuff. You do another study. You keep pointing out the inconsistencies, which I just did. And the reasoning \u2014 another inconsistency \u2014 Xiaflex has been pulled from Canada, Europe, Japan; it's not even on the formulary. You can't get it. It's still in the US. And we went through some pretty remarkable numbers a couple of weeks ago about what happens with fracture and, for example, surgery, and the incidence of erectile dysfunction.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">So why would you go to that first, when it's a series of injections that, if you pay for it, costs $21,000 \u2014 before you try something which is admitted in this article to be pretty much without side effects? Think about your PDE5 inhibitors. Okay, it's rare, but you can go blind, you can have a heart attack, profound hypotension \u2014 and all those things do happen. Or you can have a PRP injection where you might have a little pain and a bruise. And okay, maybe something comes up down the road that we don't know about \u2014 but again, 15 years.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">So that's my thinking. I could be proven wrong, but right now there's no proof either way. We have something that's still standing. And the beautiful thing about this report is that it doesn't say we're wrong \u2014 it's just asking for more studies. The only, biggest complaint I have about the arrows that come at us is: let's please listen in through the wall to the other room, to hear what the dermatologists are saying about saline injected into soft tissue not being a placebo. It's a treatment.<\/p>\n<h1 style=\"color: #b35f06; line-height: 115%; text-align: left; page-break-inside: avoid; orphans: 2; widows: 2; margin-top: 0.33in; margin-bottom: 0; direction: ltr; background: transparent; page-break-after: avoid; font-weight: bold;\" align=\"left\">A Question About the O-Shot<sup style=\"vertical-align: super; font-size: 0.9em; font-weight: bold; line-height: 0;\">\u00ae<\/sup>, Clitoxin<sup style=\"vertical-align: super; font-size: 0.9em; font-weight: bold; line-height: 0;\">\u00ae<\/sup>, and Female Ejaculation<\/h1>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">Okay, so here's the question. Let me pull this up, and I'll just give it to you the way it was sent to me. Again, these references are in your handout; the links to them are there.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">Here's the question, from one of our people who's been with us over a decade \u2014 a beautiful, smart plastic surgeon out in the western part of our United States.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">He said, \"I have a female patient ask me if the O-Shot<sup style=\"vertical-align: super; font-size: 0.9em; font-weight: bold; line-height: 0;\">\u00ae<\/sup> with botulinum toxin can help her squirt.\"<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">In other words, doing her O-Shot<sup style=\"vertical-align: super; font-size: 0.9em; font-weight: bold; line-height: 0;\">\u00ae<\/sup> and then combining it with our Clitoxin<sup style=\"vertical-align: super; font-size: 0.9em; font-weight: bold; line-height: 0;\">\u00ae<\/sup>.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">He said she was able to do so years ago, but it's less now. \"I remember you telling me that you wrote a protocol of some type on squirting. Would you please share that protocol with me?\"<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">Okay, this is what I'm going to do with that protocol. It's out there. The quick version of what happened with me: over 20 years ago \u2014 close to 30, maybe 30 years ago \u2014 I saw a woman have an ejaculatory orgasm, and there was a different emotional response, a more open emotional response, that felt like it made it easier for us to be close, versus what normally happened after a wonderful orgasm.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">So I became interested in it, read about it, was experimental with other lovers, and came up with some ideas that I think would help make that phenomenon available. So I wrote about it, and others have bought that course, which lives out there online, and I've gotten good reports. It doesn't mean it's a study; it just means it's been helpful.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">I want to be very, very clear. I don't think this needs to be the goal. There should be no real goals other than just pleasure and emotional and spiritual closeness when sex happens. It's the glue of love, it's the scaffolding of love, and it can even be a form of prayer. It can be inspiration. Many prophets and poets \u2014 and just regular people like me \u2014 have talked about that, and it happens no matter what happens in the bedroom when it's going on. I don't say that to inform you; I'm just saying it so you know I don't think teaching you about orgasm... I didn't want you to think that means I'm trying to make that the goal, or that anything less than that is some kind of failure.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">On the other hand, it is a phenomenon that happens, and I was lucky enough, one, to have what I just told you about \u2014 to have a lover who demonstrated to me that it was possible. But I also had a medical school that was somewhat progressive, because they offered a two-month sexuality course in my first or second year in Birmingham.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">And the professor, on one of the first days in class, showed a video of a woman ejaculating, and he said, \"I don't want anyone to ever leave this medical school and think that female ejaculation is not something that happens. It makes you look uninformed.\"<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">So I didn't think much about it until I witnessed it, saw that emotional response, and started thinking about it.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">I don't want this course to be in the hands of... I'll get back to the course, actually. But let me show you the anatomy and how I think it integrates with our ideas about the O-Shot<sup style=\"vertical-align: super; font-size: 0.9em; font-weight: bold; line-height: 0;\">\u00ae<\/sup> and <a href=\"https:\/\/clitoxin.com\/\"><span style=\"color: #0563c1;\"><u>Clitoxin<\/u><\/span><span style=\"color: #0563c1;\"><u><sup style=\"vertical-align: super; font-size: 0.9em; font-weight: bold; line-height: 0;\">\u00ae<\/sup><\/u><\/span><\/a>. That's the main question here. I'll get back to the course that I wrote 20 years or so ago, way before there was an O-Shot<sup style=\"vertical-align: super; font-size: 0.9em; font-weight: bold; line-height: 0;\">\u00ae<\/sup>.<\/p>\n<h1 style=\"color: #b35f06; line-height: 115%; text-align: left; page-break-inside: avoid; orphans: 2; widows: 2; margin-top: 0.33in; margin-bottom: 0; direction: ltr; background: transparent; page-break-after: avoid; font-weight: bold;\" align=\"left\">What Female Ejaculation Is: The Role of the Skene's Glands<\/h1>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">Before there was an O-Shot<sup style=\"vertical-align: super; font-size: 0.9em; font-weight: bold; line-height: 0;\">\u00ae<\/sup>, and after I had written that book about female ejaculation, the G-Shot came around. Not being a urologist or a gynecologist, I never did that. I thought it was a brilliant idea, but I never offered that procedure, because it was known to sometimes cause a granuloma.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">It's done with an HA filler, so it's been banned by ACOG. Even though the idea was brilliant, it can have problems. In one study, of 82 people who had something like that done, two of them had a granuloma significant enough to block the urethra and cause urinary obstruction requiring surgery.<a style=\"font-size: 57%;\" href=\"#sdfootnote14sym\" name=\"sdfootnote14anc\"><sup style=\"vertical-align: super; font-size: 0.9em; font-weight: bold; line-height: 0;\">14<\/sup><\/a><\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">So, if I break it and I can't fix it, I'd rather not do it. So I never did it, but I was watching the idea.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">Then, after using PRP in the face and in the penis for a while, I thought, \"All right, let's try it.\" My thinking was not anything about incontinence \u2014 that hadn't even occurred to me yet. A second patient, whom I treated for dyspareunia, told me it helped her incontinence, and then I figured, well, that's something I should have thought of.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">But the reason I chose the place where we do the injection was in regard to female ejaculation. If you look in the male, most of the volume that comes from the ejaculate comes not from the epididymis; it comes from the prostate gland. And in the female \u2014 it's not showing it in these diagrams, but there are the ducts of the Skene's glands [<span style=\"color: #0563c1;\"><u><a href=\"https:\/\/cellularmedicineassociation.org\/jcpm2026-06-23\">see video<\/a><\/u><\/span>]; they show you that much, at least. So the periurethral glands, or the Skene's glands, are equivalent to the prostate gland in a male. And in studies that have documented female ejaculation, it is true that some of the women are urinating, and that can be pleasurable \u2014 but some of them are actually excreting fluid from the periurethral glands, or the Skene's glands, and that fluid is biologically and biochemically exactly like the fluid that comes from the prostate gland. It even tests positive for PSA.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">So when I did the procedure, my idea the very first time was, \"Let me put it beneath the urethra, midline, so that it might improve the health of the periurethral glands,\" thereby improving the strength of the orgasm and facilitating ejaculatory orgasm.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">And indeed it has, in many of our patients.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">To give you an example: one of our gynecologists called me once and said, \"I'm worried. I did an O-Shot<sup style=\"vertical-align: super; font-size: 0.9em; font-weight: bold; line-height: 0;\">\u00ae<\/sup> on a woman, and now she says she's incontinent.\"<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">I said, \"Oh, I'm not sure how that would happen. Have her come to the office, and tell me what you figure out.\"<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">So the lady came to the office, and what was happening was that whenever she had an orgasm, she was squirting \u2014 having crazy, fun orgasms that were leaving her spent and happy and emotionally close \u2014 and the fluid was coming along with that. She had never had an ejaculatory orgasm and didn't know that was a thing, I guess.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">And since then, I've lost count of how many people have told me they've had one. I know I've personally seen probably a dozen, but I've heard it so many times, where they have someone past 65, past 70, who not only starts to have orgasm for the first time but starts to have ejaculatory orgasms. I don't put that out as a reason for the procedure, and you've probably never heard me talk about it, because I don't want people thinking it's a failure if that doesn't happen.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">If you do study the material I put out about that, I make it very plain that this is not some mechanical thing. Women are mysterious. The body itself, of course, is mysterious \u2014 I hesitated because that's so clich\u00e9, but as you know, there's so much that goes on with sex. I think we're still probably kindergartners in understanding it. So imagine you're with your lover, and your lover's a woman, and sex is going great, and then the fire alarm goes off, or her cell phone rings, and it's her child, or 16 other things \u2014 somebody's at work having a problem. Just the mood and the movement and the sex and the orgasm possibility itself can be interrupted and even arrested.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">It has to be in line emotionally and physically. Sex itself is the cherry on top of good health. But that ejaculatory orgasm takes patience and time and connection. Yeah, you can create something that's physical more quickly if you understand your lover's body, but for that true, emotional, spent sort of ejaculatory orgasm \u2014 that in some ways is like when a man ejaculates \u2014 I think things are going on with the pituitary gland and prolactin and oxytocin that maybe we don't even understand completely.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">So, back to how this relates to our procedures. I think the O-Shot<sup style=\"vertical-align: super; font-size: 0.9em; font-weight: bold; line-height: 0;\">\u00ae<\/sup> most definitely improves that possibility. I think it's helping make the glands healthier.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">That's the idea about what female ejaculation is. It's the female version \u2014 we all have the same parts \u2014 of the paraurethral glands, or the Skene's glands, emptying out simultaneously with orgasm. And yes, you can have a similar sensation with either urination or some form of urination, or a combination. But we do have studies showing that the fluid is not urine. We have ultrasound studies showing that in some women, it's coming from the paraurethral gland.<\/p>\n<h1 style=\"color: #b35f06; line-height: 115%; text-align: left; page-break-inside: avoid; orphans: 2; widows: 2; margin-top: 0.33in; margin-bottom: 0; direction: ltr; background: transparent; page-break-after: avoid; font-weight: bold;\" align=\"left\">Why the O-Shot<sup style=\"vertical-align: super; font-size: 0.9em; font-weight: bold; line-height: 0;\">\u00ae<\/sup> Injection Site Matters<\/h1>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">So, back to how our procedures \u2014 both the O-Shot<sup style=\"vertical-align: super; font-size: 0.9em; font-weight: bold; line-height: 0;\">\u00ae<\/sup> and Clitoxin<sup style=\"vertical-align: super; font-size: 0.9em; font-weight: bold; line-height: 0;\">\u00ae<\/sup> \u2014 can somehow contribute to that. The O-Shot<sup style=\"vertical-align: super; font-size: 0.9em; font-weight: bold; line-height: 0;\">\u00ae<\/sup>, I think, is making the paraurethral glands healthier and more voluminous, in the same way it's helping with lubrication. Not just the paraurethral glands \u2014 it's helping with lubrication.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">Two studies now have shown women with dyspareunia after treatment for breast cancer, who can't be on estrogens or don't want to be \u2014 that dryness that causes dyspareunia \u2014 we have two good studies, and we have over a decade of experience, that that's low-hanging fruit for us. The <span style=\"color: #0563c1;\"><u><a href=\"https:\/\/oshot.info\/\">O-Shot<\/a><\/u><\/span><sup style=\"vertical-align: super; font-size: 0.9em; font-weight: bold; line-height: 0;\">\u00ae<\/sup> helps those women like crazy; it lasts 9 months to 18 months.<a style=\"font-size: 57%;\" href=\"#sdfootnote15sym\" name=\"sdfootnote15anc\"><sup style=\"vertical-align: super; font-size: 0.9em; font-weight: bold; line-height: 0;\">15<\/sup><\/a><\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">So it's not just the paraurethral glands, but I think that's what's happening. Some of you need to do the studies, but I think that's what you'll find. One easy study would be to just do the straight-up O-Shot<sup style=\"vertical-align: super; font-size: 0.9em; font-weight: bold; line-height: 0;\">\u00ae<\/sup> \u2014 that one injection \u2014 but it can't be proximal to the bladder.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">I think I got lucky, and part of the reason it's helping sex is that I was thinking paraurethral glands, and injecting very distal to the bladder \u2014 second or third rugae, in the space between the urethra and the vagina. That's why I was shooting for that space: I was thinking of ejaculation in females, and orgasm, as Dr. Grafenberg taught it.<a style=\"font-size: 57%;\" href=\"#sdfootnote16sym\" name=\"sdfootnote16anc\"><sup style=\"vertical-align: super; font-size: 0.9em; font-weight: bold; line-height: 0;\">16<\/sup><\/a> I wasn't thinking urinary incontinence. But I think I got lucky, because by putting it there, hydrodissection most likely happens all the way back to the sphincter \u2014 whereas if I had been smarter and put the injection near the junction of the urethra and the bladder, it probably would not have been as good for sex, because water doesn't run uphill, and fluid doesn't hydrodissect toward an area of more tissue density.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">So I think I got lucky, but I know we're seeing it happen \u2014 that many women are having ejaculation for the first time, and even orgasm for the first time, when you do the procedure the way we teach it.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">Do you need to put extra injections over there? Before you answer that question, go take 4 cc of PRP, which is what we're using, and just inject it into someone's face. You won't get it all in. One cc is enough, subdermally, to cover the whole cheek. So I think some of the studies coming out are from people who haven't really watched the behavior of the PRP. I'm grateful that we were able to see it. I've used it for a number of months in the face, watching how it travels in the tear troughs and in the cheek. I promise you, when you put 4 cc in that midline, you're covering the whole area \u2014 probably the whole urethra, and into either side. It's a lot of fluid.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">I think that's what's happening, and why it's facilitating ejaculatory orgasm. I think it's improving the health, the neovascularization, and of course the nerves and the blood flow \u2014 but also the actual glandular tissue, I think, is probably getting healthier. There's a study for somebody: use ultrasound, measure it, check it out.<\/p>\n<h1 style=\"color: #b35f06; line-height: 115%; text-align: left; page-break-inside: avoid; orphans: 2; widows: 2; margin-top: 0.33in; margin-bottom: 0; direction: ltr; background: transparent; page-break-after: avoid; font-weight: bold;\" align=\"left\">How Clitoxin<sup style=\"vertical-align: super; font-size: 0.9em; font-weight: bold; line-height: 0;\">\u00ae<\/sup> Fits with Female Ejaculation<\/h1>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">The Clitoxin<sup style=\"vertical-align: super; font-size: 0.9em; font-weight: bold; line-height: 0;\">\u00ae<\/sup>, I don't think, is directly helping with the ejaculatory orgasm, but I do think it's helping with the orgasm, by several mechanisms. We know that in the penis, and in treating migraine, there's some strong evidence that we're attenuating sympathetic activity and therefore accentuating parasympathetic activity, which leads to harder erections and fewer migraines when we inject either the corpus cavernosum or the procerus.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">And so, if that's happening \u2014 the only study so far injecting botulinum toxin into the clitoris was the one my brilliant wife, Alexandra, and I did.<a style=\"font-size: 57%;\" href=\"#sdfootnote17sym\" name=\"sdfootnote17anc\"><sup style=\"vertical-align: super; font-size: 0.9em; font-weight: bold; line-height: 0;\">17<\/sup><\/a> But it could have never happened <span style=\"color: #0563c1;\"><u><a href=\"https:\/\/cellularmedicineassociation.org\/\">without this group<\/a><\/u><\/span>. I want to make sure you guys know: I will always, always feel blessed and grateful for the financial and moral support from this group. I try to say that at least once every time I speak from the stage \u2014 that I'm just the point man for a lot of very smart, brave, intellectually brave people.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">So directly, I don't think it's helping \u2014 except that we do have studies showing botulinum toxin also triggers neurogenesis and neovascularization.<a style=\"font-size: 57%;\" href=\"#sdfootnote18sym\" name=\"sdfootnote18anc\"><sup style=\"vertical-align: super; font-size: 0.9em; font-weight: bold; line-height: 0;\">18<\/sup><\/a> We have studies treating scar tissue in the plastic surgery and wound care literature. So there could be some of that happening. But we're not putting botulinum toxin in the anterior vaginal wall, for fear we may relax the urinary sphincter. So we're just putting it in the clitoris, and therefore it's not affecting the local tissue where the fluid comes from, where it originates when the woman has ejaculatory orgasm. So I don't think it decreases the chances of ejaculatory orgasm; but if a woman is wanting to experience that, I think she needs the O-Shot<sup style=\"vertical-align: super; font-size: 0.9em; font-weight: bold; line-height: 0;\">\u00ae<\/sup> done in the way we do it.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">And remember, also, when we combine botulinum toxin with our PRP in the clitoris \u2014 not the anterior vaginal wall \u2014 that it increased FSFI more than twice what was seen with flibanserin or bremelanotide. So that orgasm would be better, but secondarily it may help the propensity to have the pleasure of an ejaculatory orgasm.<\/p>\n<h1 style=\"color: #b35f06; line-height: 115%; text-align: left; page-break-inside: avoid; orphans: 2; widows: 2; margin-top: 0.33in; margin-bottom: 0; direction: ltr; background: transparent; page-break-after: avoid; font-weight: bold;\" align=\"left\">The Emotional and Spiritual Dimension of Orgasm<\/h1>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">And just as a sideline: there are those who \u2014 even in a woman who's had an ejaculatory orgasm \u2014 there can be this worry about the embarrassment of the fluid. What's the lover going to think? And even if she knows her lover is not going to be bothered, and they actually take pleasure in the event, both during and afterward, there can still be a reluctance that is difficult to get past sometimes, even in a woman who's had ejaculation before.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">In the Chinese Tao, it's talked about \u2014 nine levels of orgasm \u2014 and the ninth, highest level is described as a little death.<a style=\"font-size: 57%;\" href=\"#sdfootnote19sym\" name=\"sdfootnote19anc\"><sup style=\"vertical-align: super; font-size: 0.9em; font-weight: bold; line-height: 0;\">19<\/sup><\/a> The woman will also often feel like she's about to have a seizure or die right before ejaculatory orgasm and feel the need to pull back a little bit or stop. It can border on pain, and there's a mixture of fear. So I think it's one of those things where it's like we just got two kittens from the pound: you can't chase them, you have to wait for them to come to you. And it's exactly that way with ejaculatory orgasm.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">You can't chase it.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">You just fill the room with love, and sometimes it happens. But you can facilitate it.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">There's one other question I haven't answered, but while it's on my mind: if you want the course on female ejaculation, you can <span style=\"color: #0563c1;\"><u><a href=\"mailto:DrRunels@Runels.com?subject=Please%20send%20female%20ejaculation%20course\">send me an email<\/a><\/u><\/span>. I don't want to put the link here, because I want it to go to people who I think will appreciate it \u2014 and sometimes we have our metaphorical brain enemies who would like to cut down everything we do. So I'll put it in your hands if you'll shoot me an email. I'll put my best email in the chat box, and then I'll answer this last question about the amount of toxin. If you send me your email and name to that email address, I'll send you a link to my course on ejaculation.<\/p>\n<h1 style=\"color: #b35f06; line-height: 115%; text-align: left; page-break-inside: avoid; orphans: 2; widows: 2; margin-top: 0.33in; margin-bottom: 0; direction: ltr; background: transparent; page-break-after: avoid; font-weight: bold;\" align=\"left\">Botulinum Toxin Dosing with Clitoxin\u00ae: 50 Versus 100 Units<\/h1>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">Okay, last question. Wow, this one went way over \u2014 you can tell that subject is dear to my curiosity. The short answer: we covered the idea of how much you should use of Clitoxin<sup style=\"vertical-align: super; font-size: 0.9em; font-weight: bold; line-height: 0;\">\u00ae<\/sup>, which is botulinum toxin.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">When we first did the study, we knew that the Xeomin people had done a study showing that with men, if you inject 50 units, the men who had failed \u2014 who could no longer have an erection with PDE5 inhibitors \u2014 a significant number were able to achieve an erection, and it was mostly gone by 6 months. But when you injected 100 units, it would last up to 9 months to over a year.<a style=\"font-size: 57%;\" href=\"#sdfootnote20sym\" name=\"sdfootnote20anc\"><sup style=\"vertical-align: super; font-size: 0.9em; font-weight: bold; line-height: 0;\">20<\/sup><\/a> So that's what we do with Priapus Toxin<sup style=\"vertical-align: super; font-size: 0.9em; font-weight: bold; line-height: 0;\">\u00ae<\/sup>: some go up to 200 units or 300 units if the 100 doesn't work.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">With females, we weren't sure what was going to happen. Would it be nothing, or would it be persistent genital arousal disorder? So we started, and we did the paper, with 50 units. But if the mechanism is actually using the tissue as a port to get to the ganglion along the lateral vaginal wall, then the relative difference between the tissue \u2014 the volume of the clitoris versus the volume of the penis \u2014 would not matter. What matters is what you're telling the ganglion to tell the vagus nerve to tell the midbrain, because that's the path.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">So the 50 units was a first, conservative try, but we're mostly using 100 units now when we do Clitoxin<sup style=\"vertical-align: super; font-size: 0.9em; font-weight: bold; line-height: 0;\">\u00ae<\/sup>, and it seems to be working better.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">Also, this is an observation from my wife that I'll pass on. We like Daxxify in the face, but she notes it doesn't seem to work as well for the <a href=\"https:\/\/clitoxin.com\/\"><span style=\"color: #0563c1;\"><u>Clitoxin<\/u><\/span><span style=\"color: #0563c1;\"><u><sup style=\"vertical-align: super; font-size: 0.9em; font-weight: bold; line-height: 0;\">\u00ae<\/sup><\/u><\/span><\/a> or <a href=\"https:\/\/priapustoxin.com\/\"><span style=\"color: #0563c1;\"><u>Priapus Toxin<\/u><\/span><span style=\"color: #0563c1;\"><u><sup style=\"vertical-align: super; font-size: 0.9em; font-weight: bold; line-height: 0;\">\u00ae<\/sup><\/u><\/span><\/a> procedures, and there's some biology that suggests it has less of an effect on the autonomic nervous system than Botox, Xeomin, or Dysport. So we're mostly using Xeomin for our Priapus Toxin<sup style=\"vertical-align: super; font-size: 0.9em; font-weight: bold; line-height: 0;\">\u00ae<\/sup> or Clitoxin<sup style=\"vertical-align: super; font-size: 0.9em; font-weight: bold; line-height: 0;\">\u00ae<\/sup> procedure, and that's why. And we're mostly going 100 units for Clitoxin<sup style=\"vertical-align: super; font-size: 0.9em; font-weight: bold; line-height: 0;\">\u00ae<\/sup> instead of 50 \u2014 and that's why: <i><b>because it's not relative, we think, to the volume of the tissue of the clitoris or the penis. It's more of a port, with axonal transport to the ganglion, and that wouldn't really matter much, we don't think, between males and females<\/b><\/i>.<\/p>\n<h1 style=\"color: #b35f06; line-height: 115%; text-align: left; page-break-inside: avoid; orphans: 2; widows: 2; margin-top: 0.33in; margin-bottom: 0; direction: ltr; background: transparent; page-break-after: avoid; font-weight: bold;\" align=\"left\">Financing Research Through Membership<\/h1>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">So, in this journal club, I've given you at least 50 different research ideas. I'm looking at the names, and there are people on this call who can do that. So please help us out and realize that, by being in our group, you're financing at least one or two studies a year.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">We don't have the millions, but we think there are ways we might reach the million-dollar research budget. I've got a couple of nonprofits and some other ideas. So hang in there.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">Thank you for being on the call.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\"><span style=\"color: #0563c1;\"><u><a href=\"mailto:DrRunels@Runels.com?subject=please%20send%20the%20course%20about%20Female%20ejc.\">Shoot me an email to that address if you want the little course I did about female ejaculation<\/a><\/u><\/span>. Have a great week. See you next time.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">=&gt;<a href=\"https:\/\/cellularmedicineassociation.org\/procedures\/\"><span style=\"color: #0563c1;\"><u><span style=\"color: #c00000;\"> Apply for <\/span><\/u><\/span><span style=\"color: #0563c1;\"><u><span style=\"color: #c00000;\"><i>Online Training for Multiple PRP Procedures<\/i><\/span><\/u><\/span><\/a> &lt;=<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\"><span style=\"color: #0563c1;\"><u><a href=\"https:\/\/acrobat.adobe.com\/id\/urn:aaid:sc:US:bf4a1bbd-ce92-4d8f-a909-47a7d2395a0d\">=&gt;Benefits of the Cellular Medicine Association&lt;=<\/a><\/u><\/span><\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\"><span style=\"color: #0563c1;\"><u><a href=\"https:\/\/accma.memberlodge.org\/page-925782\">=&gt;Next Hands-On Workshops with Live Models&lt;=<\/a><\/u><\/span><\/p>\n<h1 style=\"color: #b35f06; line-height: 115%; text-align: left; page-break-inside: avoid; orphans: 2; widows: 2; margin-top: 0.33in; margin-bottom: 0; direction: ltr; background: transparent; page-break-after: avoid; font-weight: bold;\" align=\"left\">References<\/h1>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; text-indent: -0.5in; margin-left: 0.5in;\" align=\"left\"><span style=\"font-family: Gill Sans MT, serif;\">Anastasiadis, Eleni, Razna Ahmed, Abbas Khizar Khoja, and Tet Yap. \u201cErectile Dysfunction: Is Platelet-Rich Plasma the New Frontier for Treatment in Patients with Erectile Dysfunction? A Review of the Existing Evidence.\u201d <\/span><span style=\"font-family: Gill Sans MT, serif;\"><i>Frontiers in Reproductive Health<\/i><\/span><span style=\"font-family: Gill Sans MT, serif;\"> 4 (August 2022): 944765. https:\/\/doi.org\/10.3389\/frph.2022.944765.<\/span><\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; text-indent: -0.5in; margin-left: 0.5in;\" align=\"left\"><span style=\"font-family: Gill Sans MT, serif;\">Aru, Roberto Giorgio, Somjade Jay Songcharoen, Samantha R. Seals, Peter B. Arnold, and Robert L. Hester. \u201cMicrocirculatory Effects of Botulinum Toxin A in the Rat: Acute and Chronic Vasodilation.\u201d <\/span><span style=\"font-family: Gill Sans MT, serif;\"><i>Annals of Plastic Surgery<\/i><\/span><span style=\"font-family: Gill Sans MT, serif;\"> 79, no. 1 (2017): 82\u201385. https:\/\/doi.org\/10.1097\/SAP.0000000000001054.<\/span><\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; text-indent: -0.5in; margin-left: 0.5in;\" align=\"left\"><span style=\"font-family: Gill Sans MT, serif;\">Bindal, Priyadarshni, Nareshwaran Gnanasegaran, Umesh Bindal, et al. \u201cAngiogenic Effect of Platelet-Rich Concentrates on Dental Pulp Stem Cells in Inflamed Microenvironment.\u201d <\/span><span style=\"font-family: Gill Sans MT, serif;\"><i>Clinical Oral Investigations<\/i><\/span><span style=\"font-family: Gill Sans MT, serif;\"> 23, no. 10 (2019): 3821\u201331. https:\/\/doi.org\/10.1007\/s00784-019-02811-5.<\/span><\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; text-indent: -0.5in; margin-left: 0.5in;\" align=\"left\"><span style=\"font-family: Gill Sans MT, serif;\">Chen, Anita H., Emanuel C. Trabuco, Saranya Chumsri, et al. \u201cPlatelet-Rich Plasma for Genitourinary Syndrome of Menopause in Breast Cancer Survivors.\u201d <\/span><span style=\"font-family: Gill Sans MT, serif;\"><i>Obstetrics &amp; Gynecology<\/i><\/span><span style=\"font-family: Gill Sans MT, serif;\">, ahead of print, September 19, 2025. https:\/\/doi.org\/10.1097\/AOG.0000000000006081.<\/span><\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; text-indent: -0.5in; margin-left: 0.5in;\" align=\"left\"><span style=\"font-family: Gill Sans MT, serif;\">Chung. \u201cA Review of Current and Emerging Therapeutic Options for Erectile Dysfunction.\u201d <\/span><span style=\"font-family: Gill Sans MT, serif;\"><i>Medical Sciences<\/i><\/span><span style=\"font-family: Gill Sans MT, serif;\"> 7, no. 9 (2019): 91. https:\/\/doi.org\/10.3390\/medsci7090091.<\/span><\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; text-indent: -0.5in; margin-left: 0.5in;\" align=\"left\"><span style=\"font-family: Gill Sans MT, serif;\">Chung, Doo Yong, Ji-Kan Ryu, and Guo Nan Yin. \u201cRegenerative Therapies as a Potential Treatment of Erectile Dysfunction.\u201d <\/span><span style=\"font-family: Gill Sans MT, serif;\"><i>Investigative and Clinical Urology<\/i><\/span><span style=\"font-family: Gill Sans MT, serif;\"> 64, no. 4 (2023): 312\u201324. https:\/\/doi.org\/10.4111\/icu.20230104.<\/span><\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; text-indent: -0.5in; margin-left: 0.5in;\" align=\"left\"><span style=\"font-family: Gill Sans MT, serif;\">Chung, Eric. <\/span><span style=\"font-family: Gill Sans MT, serif;\"><i>Medical Sciences A Review of Current and Emerging Therapeutic Options for Erectile Dysfunction<\/i><\/span><span style=\"font-family: Gill Sans MT, serif;\">. 2019, 1\u201311.<\/span><\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; text-indent: -0.5in; margin-left: 0.5in;\" align=\"left\"><span style=\"font-family: Gill Sans MT, serif;\">Decu, Laurentiu. \u201c(Taoism) Chang, Stephen - The Tao of Sexology.\u201d <\/span><span style=\"font-family: Gill Sans MT, serif;\"><i>(Taoism) Chang, Stephen - The Tao of Sexology<\/i><\/span><span style=\"font-family: Gill Sans MT, serif;\">, n.d. Accessed July 1, 2026. https:\/\/www.academia.edu\/125299964\/_Taoism_Chang_Stephen_The_Tao_of_Sexology.<\/span><\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; text-indent: -0.5in; margin-left: 0.5in;\" align=\"left\"><span style=\"font-family: Gill Sans MT, serif;\">Disphanurat, Wareeporn, Wongsiya Viarasilpa, and Peera Thienpaitoon. \u201cEfficacy of Botulinum Toxin A for Scar Prevention After Breast Augmentation: A Randomized Double-Blind Intraindividual Controlled Trial.\u201d <\/span><span style=\"font-family: Gill Sans MT, serif;\"><i>Dermatologic Surgery<\/i><\/span><span style=\"font-family: Gill Sans MT, serif;\"> 47, no. 12 (2021): 1573\u201378. https:\/\/doi.org\/10.1097\/DSS.0000000000003198.<\/span><\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; text-indent: -0.5in; margin-left: 0.5in;\" align=\"left\"><span style=\"font-family: Gill Sans MT, serif;\">Dogan, Kazim, and G\u00f6khan Cil. \u201cErectile Function Recovery Using Shockwave and Platelet-Rich Plasma: A Single-Centre Prospective Comparative Study.\u201d <\/span><span style=\"font-family: Gill Sans MT, serif;\"><i>Archivos Espa\u00f1oles de Urolog\u00eda<\/i><\/span><span style=\"font-family: Gill Sans MT, serif;\"> 78, no. 8 (2025): 1029. https:\/\/doi.org\/10.56434\/j.arch.esp.urol.20257808.135.<\/span><\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; text-indent: -0.5in; margin-left: 0.5in;\" align=\"left\"><span style=\"font-family: Gill Sans MT, serif;\">Du, Shaokang, Shiwei Sun, Fuyu Guo, and Hongyao Liu. \u201cEfficacy of Platelet-Rich Plasma in the Treatment of Erectile Dysfunction: A Meta-Analysis of Controlled and Single-Arm Trials.\u201d <\/span><span style=\"font-family: Gill Sans MT, serif;\"><i>PLOS ONE<\/i><\/span><span style=\"font-family: Gill Sans MT, serif;\"> 19, no. 11 (2024): e0313074. https:\/\/doi.org\/10.1371\/journal.pone.0313074.<\/span><\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; text-indent: -0.5in; margin-left: 0.5in;\" align=\"left\"><span style=\"font-family: Gill Sans MT, serif;\">Duchen, L. W., and Sabina J. Strich. \u201cTHE EFFECTS OF BOTULINUM TOXIN ON THE PATTERN OF INNERVATION OF SKELETAL MUSCLE IN THE MOUSE.\u201d <\/span><span style=\"font-family: Gill Sans MT, serif;\"><i>Quarterly Journal of Experimental Physiology and Cognate Medical Sciences<\/i><\/span><span style=\"font-family: Gill Sans MT, serif;\"> 53, no. 1 (1968): 84\u201389. https:\/\/doi.org\/10.1113\/expphysiol.1968.sp001948.<\/span><\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; text-indent: -0.5in; margin-left: 0.5in;\" align=\"left\"><span style=\"font-family: Gill Sans MT, serif;\">El-Shaer, Waleed, Hussein Ghanem, Tamer Diab, Ahmed Abo-Taleb, and Wael Kandeel. \u201cIntra-Cavernous Injection of BOTOX\u00ae (50 and 100 Units) for Treatment of Vasculogenic Erectile Dysfunction: Randomized Controlled Trial.\u201d <\/span><span style=\"font-family: Gill Sans MT, serif;\"><i>Andrology<\/i><\/span><span style=\"font-family: Gill Sans MT, serif;\"> 9, no. 4 (2021): 1166\u201375. https:\/\/doi.org\/10.1111\/andr.13010.<\/span><\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; text-indent: -0.5in; margin-left: 0.5in;\" align=\"left\"><span style=\"font-family: Gill Sans MT, serif;\">Fasano, Giorgio, Luca Grimaldi, Giuseppe Nisi, Natale Calomino, and Roberto Cuomo. \u201cThe Regenerative Effects of Botulinum Toxin A: New Perspectives.\u201d <\/span><span style=\"font-family: Gill Sans MT, serif;\"><i>Journal of Investigative Surgery<\/i><\/span><span style=\"font-family: Gill Sans MT, serif;\"> 35, no. 5 (2022): 1074\u201375. https:\/\/doi.org\/10.1080\/08941939.2021.2008553.<\/span><\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; text-indent: -0.5in; margin-left: 0.5in;\" align=\"left\"><span style=\"font-family: Gill Sans MT, serif;\">Foy, Christian A., William F. Micheo, and Damien P. Kuffler. \u201cFunctional Recovery Following Repair of Long Nerve Gaps in Senior Patient 2.6 Years Posttrauma.\u201d <\/span><span style=\"font-family: Gill Sans MT, serif;\"><i>Plastic and Reconstructive Surgery. Global Open<\/i><\/span><span style=\"font-family: Gill Sans MT, serif;\"> 9, no. 9 (2021): e3831. https:\/\/doi.org\/10.1097\/GOX.0000000000003831.<\/span><\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; text-indent: -0.5in; margin-left: 0.5in;\" align=\"left\"><span style=\"font-family: Gill Sans MT, serif;\">Francomano, Davide, Stefano Iuliano, Federico Deh\u00f2, et al. \u201cRegenerative Treatment with Platelet-Rich Plasma in Patients with Refractory Erectile Dysfunction: Short-Term Outcomes and Predictive Value of Mean Platelet Volume.\u201d <\/span><span style=\"font-family: Gill Sans MT, serif;\"><i>Minerva Endocrinology<\/i><\/span><span style=\"font-family: Gill Sans MT, serif;\">, ahead of print, September 2023. https:\/\/doi.org\/10.23736\/S2724-6507.23.04060-5.<\/span><\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; text-indent: -0.5in; margin-left: 0.5in;\" align=\"left\"><span style=\"font-family: Gill Sans MT, serif;\">Franz, Colin K., Alyssa Puritz, Lewis A. Jordan, et al. \u201cBotulinum Toxin Conditioning Enhances Motor Axon Regeneration in Mouse and Human Preclinical Models.\u201d <\/span><span style=\"font-family: Gill Sans MT, serif;\"><i>Neurorehabilitation and Neural Repair<\/i><\/span><span style=\"font-family: Gill Sans MT, serif;\"> 32, no. 8 (2018): 735\u201345. https:\/\/doi.org\/10.1177\/1545968318790020.<\/span><\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; text-indent: -0.5in; margin-left: 0.5in;\" align=\"left\"><span style=\"font-family: Gill Sans MT, serif;\">Geyik, Serdar. \u201cComparison of the Efficacy of Low-Intensity Shock Wave Therapy and Its Combination with Platelet-Rich Plasma in Patients with Erectile Dysfunction.\u201d <\/span><span style=\"font-family: Gill Sans MT, serif;\"><i>Andrologia<\/i><\/span><span style=\"font-family: Gill Sans MT, serif;\"> 53, no. 10 (2021): e14197. https:\/\/doi.org\/10.1111\/and.14197.<\/span><\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; text-indent: -0.5in; margin-left: 0.5in;\" align=\"left\"><span style=\"font-family: Gill Sans MT, serif;\">Ghanem, Laura, Najwaa Kirmani, Mar\u00eda Paula Palacios-Ortiz, et al. \u201cComparison of Single-Spin to Double-Spin Platelet-Rich Plasma Centrifugation Methods in the Treatment of Androgenic Alopecia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.\u201d <\/span><span style=\"font-family: Gill Sans MT, serif;\"><i>Frontiers in Medicine<\/i><\/span><span style=\"font-family: Gill Sans MT, serif;\"> 12 (July 2025): 1631087. https:\/\/doi.org\/10.3389\/fmed.2025.1631087.<\/span><\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; text-indent: -0.5in; margin-left: 0.5in;\" align=\"left\"><span style=\"font-family: Gill Sans MT, serif;\">Giuliano, Francois, Pierre Denys, and Charles Joussain. \u201cEffectiveness and Safety of Intracavernosal IncobotulinumtoxinA (Xeomin\u00ae) 100 U as an Add-on Therapy to Standard Pharmacological Treatment for Difficult-to-Treat Erectile Dysfunction: A Case Series.\u201d <\/span><span style=\"font-family: Gill Sans MT, serif;\"><i>Toxins<\/i><\/span><span style=\"font-family: Gill Sans MT, serif;\"> 14, no. 4 (2022): 286. https:\/\/doi.org\/10.3390\/toxins14040286.<\/span><\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; text-indent: -0.5in; margin-left: 0.5in;\" align=\"left\"><span style=\"font-family: Gill Sans MT, serif;\">GR\u00c4FENBERG, Ernest. \u201cThe Role of Urethra in Female Orgasm.\u201d <\/span><span style=\"font-family: Gill Sans MT, serif;\"><i>The International Journal of Sexology<\/i><\/span><span style=\"font-family: Gill Sans MT, serif;\"> III, no. 3 (1950): 145\u201348.<\/span><\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; text-indent: -0.5in; margin-left: 0.5in;\" align=\"left\"><span style=\"font-family: Gill Sans MT, serif;\">Hersant, Barbara, Mounia SidAhmed-Mezi, Yazid Belkacemi, et al. \u201cEfficacy of Injecting Platelet Concentrate Combined with Hyaluronic Acid for the Treatment of Vulvovaginal Atrophy in Postmenopausal Women with History of Breast Cancer.\u201d <\/span><span style=\"font-family: Gill Sans MT, serif;\"><i>Menopause<\/i><\/span><span style=\"font-family: Gill Sans MT, serif;\"> 25, no. 10 (2018): 1. https:\/\/doi.org\/10.1097\/GME.0000000000001122.<\/span><\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; text-indent: -0.5in; margin-left: 0.5in;\" align=\"left\"><span style=\"font-family: Gill Sans MT, serif;\">Huang, Long, Zongshuai Gao, Xiang Ren, Zhufan Xu, and Changtai Zhu. \u201cPlatelet-Rich Plasma in Selected Urological Conditions: A Narrative Review of Biological Rationale, Current Evidence, and Limitations.\u201d <\/span><span style=\"font-family: Gill Sans MT, serif;\"><i>Translational Andrology and Urology<\/i><\/span><span style=\"font-family: Gill Sans MT, serif;\"> 15, no. 5 (2026): 182\u2013182. https:\/\/doi.org\/10.21037\/tau-2026-1-0084.<\/span><\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; text-indent: -0.5in; margin-left: 0.5in;\" align=\"left\"><span style=\"font-family: Gill Sans MT, serif;\">Legiawati, Lili, Shannaz Nadia Yusharyahya, Irma Bernadette, et al. \u201cComparing Single-Spin Versus Double-Spin Platelet-Rich Plasma (PRP) Centrifugation Methods on Thrombocyte Count and Clinical Improvement of Androgenetic Alopecia: A Preliminary, Randomized, Double-Blind Clinical Trial.\u201d <\/span><span style=\"font-family: Gill Sans MT, serif;\"><i>The Journal of Clinical and Aesthetic Dermatology<\/i><\/span><span style=\"font-family: Gill Sans MT, serif;\"> 16, no. 12 (2023): 39\u201344. https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10729807\/.<\/span><\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; text-indent: -0.5in; margin-left: 0.5in;\" align=\"left\"><span style=\"font-family: Gill Sans MT, serif;\">Lewandowski, Mi\u0142osz, Zuzanna \u015awierczewska, and Wioletta Bara\u0144ska-Rybak. \u201cOff-Label Use of Botulinum Toxin in Dermatology\u2014Current State of the Art.\u201d <\/span><span style=\"font-family: Gill Sans MT, serif;\"><i>Molecules<\/i><\/span><span style=\"font-family: Gill Sans MT, serif;\"> 27, no. 10 (2022): 3143. https:\/\/doi.org\/10.3390\/molecules27103143.<\/span><\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; text-indent: -0.5in; margin-left: 0.5in;\" align=\"left\"><span style=\"font-family: Gill Sans MT, serif;\">Li, Yuan, Shan Mou, Peng Xiao, et al. \u201cDelayed Two Steps PRP Injection Strategy for the Improvement of Fat Graft Survival with Superior Angiogenesis.\u201d <\/span><span style=\"font-family: Gill Sans MT, serif;\"><i>Scientific Reports<\/i><\/span><span style=\"font-family: Gill Sans MT, serif;\"> 10 (March 2020): 5231. https:\/\/doi.org\/10.1038\/s41598-020-61891-6.<\/span><\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; text-indent: -0.5in; margin-left: 0.5in;\" align=\"left\"><span style=\"font-family: Gill Sans MT, serif;\">Long, Cheng-Yu, Chieh-Yu Chang, I.-Chieh Sung, Liang-Ying Ke, and Hui-Yu Chuang. \u201cEffect of Combining Low Intensity-Extracorporeal Shockwave Therapy with Platelet-Rich Plasma among Female Patients with Interstitial Cystitis: A Prospective Single-Arm Pilot Study.\u201d <\/span><span style=\"font-family: Gill Sans MT, serif;\"><i>Frontiers in Bioengineering and Biotechnology<\/i><\/span><span style=\"font-family: Gill Sans MT, serif;\"> 14 (May 2026): 1801578. https:\/\/doi.org\/10.3389\/fbioe.2026.1801578.<\/span><\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; text-indent: -0.5in; margin-left: 0.5in;\" align=\"left\"><span style=\"font-family: Gill Sans MT, serif;\">Masterson, Thomas A., Manuel Molina, Braian Ledesma, et al. \u201cPlatelet-Rich Plasma for the Treatment of Erectile Dysfunction: A Prospective, Randomized, Double-Blind, Placebo-Controlled Clinical Trial.\u201d <\/span><span style=\"font-family: Gill Sans MT, serif;\"><i>Journal of Urology<\/i><\/span><span style=\"font-family: Gill Sans MT, serif;\">, April 30, 2023, 10.1097\/JU.0000000000003481. https:\/\/doi.org\/10.1097\/JU.0000000000003481.<\/span><\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; text-indent: -0.5in; margin-left: 0.5in;\" align=\"left\"><span style=\"font-family: Gill Sans MT, serif;\">Matz, Ethan L., Kyle Scarberry, and Ryan Terlecki. \u201cPlatelet-Rich Plasma and Cellular Therapies for Sexual Medicine and Beyond.\u201d <\/span><span style=\"font-family: Gill Sans MT, serif;\"><i>Sexual Medicine Reviews<\/i><\/span><span style=\"font-family: Gill Sans MT, serif;\"> 10, no. 1 (2022): 174\u201379. https:\/\/doi.org\/10.1016\/j.sxmr.2020.07.001.<\/span><\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; text-indent: -0.5in; margin-left: 0.5in;\" align=\"left\"><span style=\"font-family: Gill Sans MT, serif;\">Narasimman, Manish, Max Sandler, Ari Bernstein, et al. \u201cA Primer on the Restorative Therapies for Erectile Dysfunction: A Narrative Review.\u201d <\/span><span style=\"font-family: Gill Sans MT, serif;\"><i>Sexual Medicine Reviews<\/i><\/span><span style=\"font-family: Gill Sans MT, serif;\">, March 17, 2024, qeae012. https:\/\/doi.org\/10.1093\/sxmrev\/qeae012.<\/span><\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; text-indent: -0.5in; margin-left: 0.5in;\" align=\"left\"><span style=\"font-family: Gill Sans MT, serif;\">Norooznezhad, Amir Hossein. \u201cDecreased Pain in Patients Undergoing Pilonidal Sinus Surgery Treated with Platelet-Rich Plasma Therapy: The Role of Angiogenesis.\u201d <\/span><span style=\"font-family: Gill Sans MT, serif;\"><i>Advances in Skin &amp; Wound Care<\/i><\/span><span style=\"font-family: Gill Sans MT, serif;\"> 33, no. 1 (2020): 8. https:\/\/doi.org\/10.1097\/01.ASW.0000615376.97232.0a.<\/span><\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; text-indent: -0.5in; margin-left: 0.5in;\" align=\"left\"><span style=\"font-family: Gill Sans MT, serif;\">Park, Hyung Joo, Ki Hwan Jung, Sun Young Kim, Ju-Han Lee, Jin Yong Jeong, and Je Hyeong Kim. \u201cHyaluronic Acid Pulmonary Embolism: A Critical Consequence of an Illegal Cosmetic Vaginal Procedure.\u201d Case Report. <\/span><span style=\"font-family: Gill Sans MT, serif;\"><i>Thorax<\/i><\/span><span style=\"font-family: Gill Sans MT, serif;\"> 65, no. 4 (2010): 360\u201361. https:\/\/doi.org\/10.1136\/thx.2009.128272.<\/span><\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; text-indent: -0.5in; margin-left: 0.5in;\" align=\"left\"><span style=\"font-family: Gill Sans MT, serif;\">Poulios, Evangelos, Ioannis Mykoniatis, Nikolaos Pyrgidis, et al. \u201cPlatelet-Rich Plasma (PRP) Improves Erectile Function: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial.\u201d <\/span><span style=\"font-family: Gill Sans MT, serif;\"><i>Journal of Sexual Medicine<\/i><\/span><span style=\"font-family: Gill Sans MT, serif;\"> 18, no. 5 (2021): 926\u201335. https:\/\/doi.org\/10.1016\/j.jsxm.2021.03.008.<\/span><\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; text-indent: -0.5in; margin-left: 0.5in;\" align=\"left\"><span style=\"font-family: Gill Sans MT, serif;\">Ruffo, A., M. Franco, E. Illiano, and N. Stanojevic. \u201cEffectiveness and Safety of Platelet Rich Plasma (PrP) Cavernosal Injections plus External Shock Wave Treatment for Penile Erectile Dysfunction: First Results from a Prospective, Randomized, Controlled, Interventional Study.\u201d <\/span><span style=\"font-family: Gill Sans MT, serif;\"><i>European Urology Supplements<\/i><\/span><span style=\"font-family: Gill Sans MT, serif;\"> 18, no. 1 (2019): e1622\u201323. https:\/\/doi.org\/10.1016\/S1569-9056(19)31175-3.<\/span><\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; text-indent: -0.5in; margin-left: 0.5in;\" align=\"left\"><span style=\"font-family: Gill Sans MT, serif;\">Runels, Charles, and Alexandra Runnels. \u201cThe Clitoral Injection of IncobotulinumtoxinA for the Improvement of Arousal, Orgasm &amp; Sexual Satisfaction- A Specific Method and the Effects on Women.\u201d <\/span><span style=\"font-family: Gill Sans MT, serif;\"><i>Journal of Women\u2019s Health Care<\/i><\/span><span style=\"font-family: Gill Sans MT, serif;\"> 13, no. 3 No. 715 (2024). https:\/\/doi.org\/10.35248\/2167-0420.24.13.715.<\/span><\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; text-indent: -0.5in; margin-left: 0.5in;\" align=\"left\"><span style=\"font-family: Gill Sans MT, serif;\">Saleh, Doaa M., and Rania Abdelghani. \u201cClinical Evaluation of Autologous Platelet Rich Plasma Injection in Postmenopausal Vulvovaginal Atrophy: A Pilot Study.\u201d <\/span><span style=\"font-family: Gill Sans MT, serif;\"><i>Journal of Cosmetic Dermatology<\/i><\/span><span style=\"font-family: Gill Sans MT, serif;\"> n\/a, no. n\/a (n.d.). https:\/\/doi.org\/10.1111\/jocd.14873.<\/span><\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; text-indent: -0.5in; margin-left: 0.5in;\" align=\"left\"><span style=\"font-family: Gill Sans MT, serif;\">S\u00e1nchez, Mikel, Eduardo Anitua, Diego Delgado, et al. \u201cPlatelet-Rich Plasma, a Source of Autologous Growth Factors and Biomimetic Scaffold for Peripheral Nerve Regeneration.\u201d <\/span><span style=\"font-family: Gill Sans MT, serif;\"><i>Expert Opinion on Biological Therapy<\/i><\/span><span style=\"font-family: Gill Sans MT, serif;\"> 17, no. 2 (2017): 197\u2013212. https:\/\/doi.org\/10.1080\/14712598.2017.1259409.<\/span><\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; text-indent: -0.5in; margin-left: 0.5in;\" align=\"left\"><span style=\"font-family: Gill Sans MT, serif;\">Schirmann, A., E. Boutin, A. Faix, and R. Yiou. \u201cPilot Study of Intra-Cavernous Injections of Platelet-Rich Plasma (P-Shot\u00ae) in the Treatment of Vascular Erectile Dysfunction.\u201d <\/span><span style=\"font-family: Gill Sans MT, serif;\"><i>Progres En Urologie: Journal De l\u2019Association Francaise D\u2019urologie Et De La Societe Francaise D\u2019urologie<\/i><\/span><span style=\"font-family: Gill Sans MT, serif;\">, June 10, 2022, S1166-7087(22)00130-0. https:\/\/doi.org\/10.1016\/j.purol.2022.05.002.<\/span><\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; text-indent: -0.5in; margin-left: 0.5in;\" align=\"left\"><span style=\"font-family: Gill Sans MT, serif;\">Sclafani, Anthony P., and Steven A. McCormick. \u201cInduction of Dermal Collagenesis, Angiogenesis, and Adipogenesis in Human Skin by Injection of Platelet-Rich Fibrin Matrix.\u201d <\/span><span style=\"font-family: Gill Sans MT, serif;\"><i>Archives of Facial Plastic Surgery<\/i><\/span><span style=\"font-family: Gill Sans MT, serif;\"> 14, no. 2 (2012): 132\u201336. https:\/\/doi.org\/10.1001\/archfacial.2011.784.<\/span><\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; text-indent: -0.5in; margin-left: 0.5in;\" align=\"left\"><span style=\"font-family: Gill Sans MT, serif;\">Shaher, Hussein, Abdallah Fathi, Salah Elbashir, Shabieb A. Abdelbaki, and Tarek Soliman. \u201cIs Platelet Rich Plasma Safe And Effective In Treatment Of Erectile Dysfunction? Randomized Controlled Study.\u201d <\/span><span style=\"font-family: Gill Sans MT, serif;\"><i>Urology<\/i><\/span><span style=\"font-family: Gill Sans MT, serif;\">, February 2023, S0090429523000742. https:\/\/doi.org\/10.1016\/j.urology.2023.01.028.<\/span><\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; text-indent: -0.5in; margin-left: 0.5in;\" align=\"left\"><span style=\"font-family: Gill Sans MT, serif;\">Siroky, Mike B., and Kazem M. Azadzoi. \u201cVasculogenic Erectile Dysfunction: Newer Therapeutic Strategies.\u201d <\/span><span style=\"font-family: Gill Sans MT, serif;\"><i>Journal of Urology<\/i><\/span><span style=\"font-family: Gill Sans MT, serif;\"> 170, no. 2S (2003). https:\/\/doi.org\/10.1097\/01.ju.0000075361.35942.17.<\/span><\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; text-indent: -0.5in; margin-left: 0.5in;\" align=\"left\"><span style=\"font-family: Gill Sans MT, serif;\">Ta\u015f, Tuncay, Basri \u00c7ak\u0131ro<\/span><span style=\"font-family: Calibri, serif;\">\u011f<\/span><span style=\"font-family: Gill Sans MT, serif;\">lu, Ersan Arda, \u00d6zkan Onuk, and Bar\u0131\u015f Nuho<\/span><span style=\"font-family: Calibri, serif;\">\u011f<\/span><span style=\"font-family: Gill Sans MT, serif;\">lu. \u201cEarly Clinical Results of the Tolerability, Safety, and Efficacy of Autologous Platelet-Rich Plasma Administration in Erectile Dysfunction.\u201d <\/span><span style=\"font-family: Gill Sans MT, serif;\"><i>Sexual Medicine<\/i><\/span><span style=\"font-family: Gill Sans MT, serif;\"> 9, no. 2 (2021): 100313. https:\/\/doi.org\/10.1016\/j.esxm.2020.100313.<\/span><\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; text-indent: -0.5in; margin-left: 0.5in;\" align=\"left\"><span style=\"font-family: Gill Sans MT, serif;\">Toloui, Amirmohammad, Hamzah Adel Ramawad, Nahid Aboutaleb, and Mahmoud Yousefifard. \u201cEffectiveness of Platelet-Rich Plasma in Treating Spinal Cord Injuries: A Systematic Review &amp; Meta-Analysis.\u201d <\/span><span style=\"font-family: Gill Sans MT, serif;\"><i>Basic and Clinical Neuroscience<\/i><\/span><span style=\"font-family: Gill Sans MT, serif;\"> 15, no. 4 (2024): 443\u201354. https:\/\/doi.org\/10.32598\/bcn.2023.562.2.<\/span><\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; text-indent: -0.5in; margin-left: 0.5in;\" align=\"left\"><span style=\"font-family: Gill Sans MT, serif;\">Towe, Maxwell, Akhil Peta, Russell G. Saltzman, Navin Balaji, Kevin Chu, and Ranjith Ramasamy. \u201cThe Use of Combination Regenerative Therapies for Erectile Dysfunction: Rationale and Current Status.\u201d <\/span><span style=\"font-family: Gill Sans MT, serif;\"><i>International Journal of Impotence Research<\/i><\/span><span style=\"font-family: Gill Sans MT, serif;\">, July 12, 2021, 1\u20134. https:\/\/doi.org\/10.1038\/s41443-021-00456-1.<\/span><\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; text-indent: -0.5in; margin-left: 0.5in;\" align=\"left\">\u201c<span style=\"font-family: Gill Sans MT, serif;\">Vampire Facials Linked to Two Confirmed Cases of HIV In New Mexico.\u201d Accessed July 1, 2026. https:\/\/www.rollingstone.com\/culture\/culture-news\/vampire-facials-hiv-new-mexico-risks-benefits-829686\/.<\/span><\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; text-indent: -0.5in; margin-left: 0.5in;\" align=\"left\"><span style=\"font-family: Gill Sans MT, serif;\">Virag, R. \u201cINTRACAVERNOUS INJECTION OF PAPAVERINE FOR ERECTILE FAILURE.\u201d <\/span><span style=\"font-family: Gill Sans MT, serif;\"><i>The Lancet<\/i><\/span><span style=\"font-family: Gill Sans MT, serif;\"> 320, no. 8304 (1982): 938. https:\/\/doi.org\/10.1016\/S0140-6736(82)90910-2.<\/span><\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; text-indent: -0.5in; margin-left: 0.5in;\" align=\"left\"><span style=\"font-family: Gill Sans MT, serif;\">Virag, Ronald, H\u00e9l\u00e8ne Sussman, Sandrine Lambion, and Val\u00e9rie de Fourmestraux. \u201cEvaluation of the Benefit of Using a Combination of Autologous Platelet Rich-Plasma and Hyaluronic Acid for the Treatment of Peyronie\u2019s Disease.\u201d <\/span><span style=\"font-family: Gill Sans MT, serif;\"><i>Sexual Health Issues<\/i><\/span><span style=\"font-family: Gill Sans MT, serif;\"> 1, no. 1 (2017). https:\/\/doi.org\/10.15761\/SHI.1000102.<\/span><\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; text-indent: -0.5in; margin-left: 0.5in;\" align=\"left\"><span style=\"font-family: Gill Sans MT, serif;\"><i>Wikipedia<\/i><\/span><span style=\"font-family: Gill Sans MT, serif;\">. \u201cRonald Virag.\u201d September 11, 2024. https:\/\/en.wikipedia.org\/w\/index.php?title=Ronald_Virag&amp;oldid=1245099330.<\/span><\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; text-indent: -0.5in; margin-left: 0.5in;\" align=\"left\"><span style=\"font-family: Gill Sans MT, serif;\">Williams, Kimberly N., and Antonella Tosti. \u201cPlatelet-Rich Plasma Devices in Dermatology.\u201d <\/span><span style=\"font-family: Gill Sans MT, serif;\"><i>Dermatologic Clinics<\/i><\/span><span style=\"font-family: Gill Sans MT, serif;\"> 44, no. 3 (2026): 435\u201342. https:\/\/doi.org\/10.1016\/j.det.2026.02.002.<\/span><\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; text-indent: -0.5in; margin-left: 0.5in;\" align=\"left\"><span style=\"font-family: Gill Sans MT, serif;\">Willison, Nadia, Fariba Behnia-Willison, Pouria Aryan, et al. \u201cApplication of Platelet-Rich Plasma in Gynaecologic Disorders: A Scoping Review.\u201d <\/span><span style=\"font-family: Gill Sans MT, serif;\"><i>Journal of Clinical Medicine<\/i><\/span><span style=\"font-family: Gill Sans MT, serif;\"> 14, no. 16 (2025): 5832. https:\/\/doi.org\/10.3390\/jcm14165832.<\/span><\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; text-indent: -0.5in; margin-left: 0.5in;\" align=\"left\"><span style=\"font-family: Gill Sans MT, serif;\">Wu, Yi-No, Chun-Hou Liao, Kuo-Chiang Chen, and Han-Sun Chiang. \u201cDual Effect of Chitosan Activated Platelet Rich Plasma (cPRP) Improved Erectile Function after Cavernous Nerve Injury.\u201d <\/span><span style=\"font-family: Gill Sans MT, serif;\"><i>Journal of the Formosan Medical Association<\/i><\/span><span style=\"font-family: Gill Sans MT, serif;\">, ahead of print, March 27, 2021. https:\/\/doi.org\/10.1016\/j.jfma.2021.01.019.<\/span><\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; text-indent: -0.5in; margin-left: 0.5in;\" align=\"left\"><span style=\"font-family: Gill Sans MT, serif;\">Yasak, Tu<\/span><span style=\"font-family: Calibri, serif;\">\u011f<\/span><span style=\"font-family: Gill Sans MT, serif;\">\u00e7e, \u00d6zay \u00d6zkaya, Ay\u00e7a Ergan \u015eahin, and \u00d6zlem \u00c7olak. \u201cElectromyographic and Clinical Investigation of the Effect of Platelet-Rich Plasma on Peripheral Nerve Regeneration in Patients with Diabetes after Surgery for Carpal Tunnel Syndrome.\u201d <\/span><span style=\"font-family: Gill Sans MT, serif;\"><i>Archives of Plastic Surgery<\/i><\/span><span style=\"font-family: Gill Sans MT, serif;\"> 49, no. 02 (2022): 200\u2013206. https:\/\/doi.org\/10.1055\/s-0042-1744410.<\/span><\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; text-indent: -0.5in; margin-left: 0.5in;\" align=\"left\"><span style=\"font-family: Gill Sans MT, serif;\">Yogiswara, Niwanda, Fikri Rizaldi, and Mohammad Ayodhia Soebadi. \u201cThe Potential Role of Intracavernosal Injection of Platelet-Rich Plasma for Treating Patients with Mild to Moderate Erectile Dysfunction: A GRADE-Assessed Systematic Review and Meta-Analysis of Randomized Controlled Trials.\u201d <\/span><span style=\"font-family: Gill Sans MT, serif;\"><i>Archivio Italiano Di Urologia e Andrologia<\/i><\/span><span style=\"font-family: Gill Sans MT, serif;\"> 96, no. 3 (2024): 3. https:\/\/doi.org\/10.4081\/aiua.2024.12687.<\/span><\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; text-indent: -0.5in; margin-left: 0.5in;\" align=\"left\"><span style=\"font-family: Gill Sans MT, serif;\">Zhang, X. L., K. Q. Shi, P. T. Jia, et al. \u201cEffects of Platelet-Rich Plasma on Angiogenesis and Osteogenesis-Associated Factors in Rabbits with Avascular Necrosis of the Femoral Head.\u201d <\/span><span style=\"font-family: Gill Sans MT, serif;\"><i>European Review for Medical and Pharmacological Sciences<\/i><\/span><span style=\"font-family: Gill Sans MT, serif;\"> 22, no. 7 (2018): 2143\u201352. https:\/\/doi.org\/10.26355\/eurrev_201804_14748.<\/span><\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; text-indent: -0.5in; margin-left: 0.5in;\" align=\"left\"><span style=\"font-family: Gill Sans MT, serif;\">Zheng, Qiangping, Peng Zhang, Wei Guo, et al. \u201cA Standardized Protocol for Modified Platelet-Rich Plasma Collection for the Treatment of Interstitial Cystitis\/Bladder Pain Syndrome.\u201d <\/span><span style=\"font-family: Gill Sans MT, serif;\"><i>Bladder<\/i><\/span><span style=\"font-family: Gill Sans MT, serif;\"> 12, no. 1 (2025): e21200034. https:\/\/doi.org\/10.14440\/bladder.2024.0052.<\/span><\/p>\n<h1 style=\"color: #b35f06; line-height: 115%; text-align: left; page-break-inside: avoid; orphans: 2; widows: 2; margin-top: 0.33in; margin-bottom: 0; direction: ltr; background: transparent; page-break-after: avoid; font-weight: bold;\" align=\"left\">Tags<\/h1>\n<h1 style=\"color: #b35f06; line-height: 115%; text-align: left; page-break-inside: avoid; orphans: 2; widows: 2; margin-top: 0.33in; margin-bottom: 0; direction: ltr; background: transparent; page-break-after: avoid; font-weight: bold;\" align=\"left\"><span style=\"display: inline-block; border: 1px solid #ccc9e6; padding: 0in;\"><span style=\"color: #000000;\"><span style=\"font-family: Gill Sans MT, serif;\"><span style=\"font-size: small;\"><span style=\"font-weight: normal;\"><span style=\"background: #ffffff;\">O-Shot, Clitoxin, P-Shot, Priapus Toxin, female ejaculation, Skene's glands, paraurethral glands, PRP, platelet-rich plasma, botulinum toxin, Clitoxin dosing, botulinum toxin dosing, Xeomin, Daxxify, Priapus Shot, female orgasm, ejaculatory orgasm, female sexual dysfunction, dyspareunia, vaginal dryness, breast cancer survivors, urinary incontinence, PRP dermatology, alopecia, single spin PRP, double spin PRP, microneedling, PRP delivery methods, mesotherapy, shockwave therapy, GAINSWave, erectile dysfunction, interstitial cystitis, PDE5 inhibitors, saline placebo, Masterson study, Peyronie's disease, Xiaflex, Ronald Virag, informed consent, off-label, PRP research, neovascularization, neurogenesis, FSFI, flibanserin, bremelanotide, regenerative medicine, sexual medicine, Cellular Medicine Association, Journal Club with Pearls and Marketing<\/span><\/span><\/span><\/span><\/span><\/span><\/h1>\n<h1 style=\"color: #b35f06; line-height: 115%; text-align: left; page-break-inside: avoid; orphans: 2; widows: 2; margin-top: 0.33in; margin-bottom: 0; direction: ltr; background: transparent; page-break-after: avoid; font-weight: bold;\" align=\"left\">Helpful Links<\/h1>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">=&gt; <a href=\"https:\/\/accma.memberlodge.org\/page-925782\"><span style=\"color: #0563c1;\"><u><span style=\"color: #c00000;\">Next Hands-On Workshops with Live Model<\/span><\/u><\/span><span style=\"color: #0563c1;\"><u>s<\/u><\/span><\/a> &lt;=<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\"><span style=\"color: #0563c1;\"><u><a href=\"https:\/\/cellularmedicineassociation.org\/prp-training-runels\/\">=&gt;Next Hands-On Training with Live Models with Dr. Runels (includes marketing)&lt;=<\/a><\/u><\/span><\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\"><span style=\"color: #0563c1;\"><u><a href=\"https:\/\/botoxclass.com\/workshop\">=&gt;Hands On Botulinum Toxin Workshop That Teaches Medical &amp; Cosmetic Uses&lt;=<\/a><\/u><\/span><\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">=&gt; <a href=\"https:\/\/botoxclass.com\/\"><span style=\"color: #0563c1;\"><u>Dr. Runels Online <\/u><\/span><span style=\"color: #0563c1;\"><u><i>Botulinum Blastoff Course<\/i><\/u><\/span><\/a> &lt;=<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">=&gt; <span style=\"color: #0563c1;\"><u><a href=\"https:\/\/cellularmedicineassociation.org\/\"><span style=\"color: #c00000;\">The Cellular Medicine Association (who we are<\/span><\/a><\/u><\/span><span style=\"color: #c00000;\">) <\/span>&lt;=<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">=&gt;<a href=\"https:\/\/cellularmedicineassociation.org\/procedures\/\"><span style=\"color: #0563c1;\"><u> Apply for <\/u><\/span><span style=\"color: #0563c1;\"><u><i>Online Training for Multiple PRP Procedures<\/i><\/u><\/span><\/a> &lt;=<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">=&gt; <span style=\"color: #0563c1;\"><u><a href=\"https:\/\/oshot.info\/fsfi-calculator\"><span style=\"color: #c00000;\">FSFI Online Administrator and Calculator<\/span><\/a><\/u><\/span> &lt;=<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">=&gt; <span style=\"color: #0563c1;\"><u><a href=\"https:\/\/5notes.com\/\"><span style=\"color: #c00000;\">5-Notes Expert System for Doctors<\/span><\/a><\/u><\/span> &lt;=<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">=&gt;<a href=\"https:\/\/cellularmedicineassociation.org\/password\/\"><span style=\"color: #0563c1;\"><u><span style=\"color: #c00000;\"> Help with <\/span><\/u><\/span><span style=\"color: #0563c1;\"><u><span style=\"color: #c00000;\"><i>Logging into Membership Website<\/i><\/span><\/u><\/span><span style=\"color: #0563c1;\"><u><span style=\"color: #c00000;\">s<\/span><\/u><\/span><\/a> &lt;=<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">=&gt; <span style=\"color: #0563c1;\"><u><a href=\"https:\/\/ontraport.com\/Cellular-Medicine-Association-\"><span style=\"color: #c00000;\">The software I use to send emails: ONTRAPORT (free trial)<\/span><\/a><\/u><\/span> <span style=\"color: #0563c1;\"><span style=\"color: #000000;\"><span style=\"text-decoration: none;\">&lt;=<\/span><\/span><\/span><\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">=&gt; Sell O-Shot\u00ae products: You make 10% with links you place; shipped by the manufacturer), <span style=\"color: #0563c1;\"><u><a href=\"https:\/\/www.loom.com\/share\/dcd9fe2284a746a199fd7d5cc42d5f61?sid=f5a33b4b-a3ee-4fb1-b13e-2273718dce9b\"><span style=\"color: #c00000;\">this explains<\/span><\/a><\/u><\/span> and <span style=\"color: #0563c1;\"><u><a href=\"https:\/\/oshotwomen.leaddyno.com\/\"><span style=\"color: #c00000;\">here\u2019s where to apply<\/span><\/a><\/u><\/span><\/p>\n<div id=\"sdfootnote1\">\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; font-size: 10pt;\" align=\"left\"><a href=\"#sdfootnote1anc\" name=\"sdfootnote1sym\">1<\/a> <span style=\"font-family: Gill Sans MT, serif;\">Williams and Tosti, \u201cPlatelet-Rich Plasma Devices in Dermatology.\u201d<\/span><\/p>\n<\/div>\n<div id=\"sdfootnote2\">\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; font-size: 10pt;\" align=\"left\"><a href=\"#sdfootnote2anc\" name=\"sdfootnote2sym\">2<\/a> <span style=\"font-family: Gill Sans MT, serif;\">Legiawati et al., \u201cComparing Single-Spin Versus Double-Spin Platelet-Rich Plasma (PRP) Centrifugation Methods on Thrombocyte Count and Clinical Improvement of Androgenetic Alopecia\u201d; Ghanem et al., \u201cComparison of Single-Spin to Double-Spin Platelet-Rich Plasma Centrifugation Methods in the Treatment of Androgenic Alopecia.\u201d<\/span><\/p>\n<\/div>\n<div id=\"sdfootnote3\">\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; font-size: 10pt;\" align=\"left\"><a href=\"#sdfootnote3anc\" name=\"sdfootnote3sym\">3<\/a> <span style=\"font-family: Gill Sans MT, serif;\">Williams and Tosti, \u201cPlatelet-Rich Plasma Devices in Dermatology.\u201d<\/span><\/p>\n<\/div>\n<div id=\"sdfootnote4\">\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; font-size: 10pt;\" align=\"left\"><a href=\"#sdfootnote4anc\" name=\"sdfootnote4sym\">4<\/a> <span style=\"font-family: Gill Sans MT, serif;\">\u201cVampire Facials Linked to Two Confirmed Cases of HIV In New Mexico.\u201d<\/span><\/p>\n<\/div>\n<div id=\"sdfootnote5\">\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; font-size: 10pt;\" align=\"left\"><a href=\"#sdfootnote5anc\" name=\"sdfootnote5sym\">5<\/a> <span style=\"font-family: Gill Sans MT, serif;\">Chung, \u201cA Review of Current and Emerging Therapeutic Options for Erectile Dysfunction\u201d; Geyik, \u201cComparison of the Efficacy of Low-Intensity Shock Wave Therapy and Its Combination with Platelet-Rich Plasma in Patients with Erectile Dysfunction\u201d; Dogan and Cil, \u201cErectile Function Recovery Using Shockwave and Platelet-Rich Plasma.\u201d<\/span><\/p>\n<\/div>\n<div id=\"sdfootnote6\">\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; font-size: 10pt;\" align=\"left\"><a href=\"#sdfootnote6anc\" name=\"sdfootnote6sym\">6<\/a> <span style=\"font-family: Gill Sans MT, serif;\">Willison et al., \u201cApplication of Platelet-Rich Plasma in Gynaecologic Disorders\u201d; Zheng et al., \u201cA Standardized Protocol for Modified Platelet-Rich Plasma Collection for the Treatment of Interstitial Cystitis\/Bladder Pain Syndrome.\u201d<\/span><\/p>\n<\/div>\n<div id=\"sdfootnote7\">\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; font-size: 10pt;\" align=\"left\"><a href=\"#sdfootnote7anc\" name=\"sdfootnote7sym\">7<\/a> <span style=\"font-family: Gill Sans MT, serif;\">Long et al., \u201cEffect of Combining Low Intensity-Extracorporeal Shockwave Therapy with Platelet-Rich Plasma among Female Patients with Interstitial Cystitis.\u201d<\/span><\/p>\n<\/div>\n<div id=\"sdfootnote8\">\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; font-size: 10pt;\" align=\"left\"><a href=\"#sdfootnote8anc\" name=\"sdfootnote8sym\">8<\/a> <span style=\"font-family: Gill Sans MT, serif;\">Huang et al., \u201cPlatelet-Rich Plasma in Selected Urological Conditions.\u201d<\/span><\/p>\n<\/div>\n<div id=\"sdfootnote9\">\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; font-size: 10pt;\" align=\"left\"><a href=\"#sdfootnote9anc\" name=\"sdfootnote9sym\">9<\/a> <span style=\"font-family: Gill Sans MT, serif;\">Chung, \u201cA Review of Current and Emerging Therapeutic Options for Erectile Dysfunction\u201d; Narasimman et al., \u201cA Primer on the Restorative Therapies for Erectile Dysfunction\u201d; Ta\u015f et al., \u201cEarly Clinical Results of the Tolerability, Safety, and Efficacy of Autologous Platelet-Rich Plasma Administration in Erectile Dysfunction\u201d; Ruffo et al., \u201cEffectiveness and Safety of Platelet Rich Plasma (PrP) Cavernosal Injections plus External Shock Wave Treatment for Penile Erectile Dysfunction\u201d; Du et al., \u201cEfficacy of Platelet-Rich Plasma in the Treatment of Erectile Dysfunction\u201d; Anastasiadis et al., \u201cErectile Dysfunction\u201d; Shaher et al., \u201cIs Platelet Rich Plasma Safe And Effective In Treatment Of Erectile Dysfunction?\u201d; Chung, <\/span><span style=\"font-family: Gill Sans MT, serif;\"><i>Medical Sciences A Review of Current and Emerging Therapeutic Options for Erectile Dysfunction<\/i><\/span><span style=\"font-family: Gill Sans MT, serif;\">; Schirmann et al., \u201cPilot Study of Intra-Cavernous Injections of Platelet-Rich Plasma (P-Shot\u00ae) in the Treatment of Vascular Erectile Dysfunction\u201d; Poulios et al., \u201cPlatelet-Rich Plasma (PRP) Improves Erectile Function: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial\u201d; Matz et al., \u201cPlatelet-Rich Plasma and Cellular Therapies for Sexual Medicine and Beyond\u201d; Chung et al., \u201cRegenerative Therapies as a Potential Treatment of Erectile Dysfunction\u201d; Francomano et al., \u201cRegenerative Treatment with Platelet-Rich Plasma in Patients with Refractory Erectile Dysfunction\u201d; Yogiswara et al., \u201cThe Potential Role of Intracavernosal Injection of Platelet-Rich Plasma for Treating Patients with Mild to Moderate Erectile Dysfunction\u201d; Towe et al., \u201cThe Use of Combination Regenerative Therapies for Erectile Dysfunction\u201d; Siroky and Azadzoi, \u201cVasculogenic Erectile Dysfunction.\u201d<\/span><\/p>\n<\/div>\n<div id=\"sdfootnote10\">\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; font-size: 10pt;\" align=\"left\"><a href=\"#sdfootnote10anc\" name=\"sdfootnote10sym\">10<\/a> <span style=\"font-family: Gill Sans MT, serif;\">Masterson et al., \u201cPlatelet-Rich Plasma for the Treatment of Erectile Dysfunction.\u201d<\/span><\/p>\n<\/div>\n<div id=\"sdfootnote11\">\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; font-size: 10pt;\" align=\"left\"><a href=\"#sdfootnote11anc\" name=\"sdfootnote11sym\">11<\/a> <span style=\"font-family: Gill Sans MT, serif;\">Wu et al., \u201cDual Effect of Chitosan Activated Platelet Rich Plasma (cPRP) Improved Erectile Function after Cavernous Nerve Injury\u201d; Toloui et al., \u201cEffectiveness of Platelet-Rich Plasma in Treating Spinal Cord Injuries\u201d; Yasak et al., \u201cElectromyographic and Clinical Investigation of the Effect of Platelet-Rich Plasma on Peripheral Nerve Regeneration in Patients with Diabetes after Surgery for Carpal Tunnel Syndrome\u201d; Foy et al., \u201cFunctional Recovery Following Repair of Long Nerve Gaps in Senior Patient 2.6 Years Posttrauma\u201d; S\u00e1nchez et al., \u201cPlatelet-Rich Plasma, a Source of Autologous Growth Factors and Biomimetic Scaffold for Peripheral Nerve Regeneration.\u201d<\/span><\/p>\n<\/div>\n<div id=\"sdfootnote12\">\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; font-size: 10pt;\" align=\"left\"><a href=\"#sdfootnote12anc\" name=\"sdfootnote12sym\">12<\/a> <span style=\"font-family: Gill Sans MT, serif;\">Bindal et al., \u201cAngiogenic Effect of Platelet-Rich Concentrates on Dental Pulp Stem Cells in Inflamed Microenvironment\u201d; Norooznezhad, \u201cDecreased Pain in Patients Undergoing Pilonidal Sinus Surgery Treated with Platelet-Rich Plasma Therapy\u201d; Li et al., \u201cDelayed Two Steps PRP Injection Strategy for the Improvement of Fat Graft Survival with Superior Angiogenesis\u201d; Zhang et al., \u201cEffects of Platelet-Rich Plasma on Angiogenesis and Osteogenesis-Associated Factors in Rabbits with Avascular Necrosis of the Femoral Head\u201d; Sclafani and McCormick, \u201cInduction of Dermal Collagenesis, Angiogenesis, and Adipogenesis in Human Skin by Injection of Platelet-Rich Fibrin Matrix.\u201d<\/span><\/p>\n<\/div>\n<div id=\"sdfootnote13\">\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; font-size: 10pt;\" align=\"left\"><a href=\"#sdfootnote13anc\" name=\"sdfootnote13sym\">13<\/a> <span style=\"font-family: Gill Sans MT, serif;\">Virag et al., \u201cEvaluation of the Benefit of Using a Combination of Autologous Platelet Rich-Plasma and Hyaluronic Acid for the Treatment of Peyronie\u2019s Disease\u201d; Virag, \u201cINTRACAVERNOUS INJECTION OF PAPAVERINE FOR ERECTILE FAILURE\u201d; <\/span><span style=\"font-family: Gill Sans MT, serif;\"><i>Wikipedia<\/i><\/span><span style=\"font-family: Gill Sans MT, serif;\">, \u201cRonald Virag.\u201d<\/span><\/p>\n<\/div>\n<div id=\"sdfootnote14\">\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; font-size: 10pt;\" align=\"left\"><a href=\"#sdfootnote14anc\" name=\"sdfootnote14sym\">14<\/a> <span style=\"font-family: Gill Sans MT, serif;\">Park et al., \u201cHyaluronic Acid Pulmonary Embolism.\u201d<\/span><\/p>\n<\/div>\n<div id=\"sdfootnote15\">\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; font-size: 10pt;\" align=\"left\"><a href=\"#sdfootnote15anc\" name=\"sdfootnote15sym\">15<\/a> <span style=\"font-family: Gill Sans MT, serif;\">Hersant et al., \u201cEfficacy of Injecting Platelet Concentrate Combined with Hyaluronic Acid for the Treatment of Vulvovaginal Atrophy in Postmenopausal Women with History of Breast Cancer\u201d; Chen et al., \u201cPlatelet-Rich Plasma for Genitourinary Syndrome of Menopause in Breast Cancer Survivors\u201d; Saleh and Abdelghani, \u201cClinical Evaluation of Autologous Platelet Rich Plasma Injection in Postmenopausal Vulvovaginal Atrophy.\u201d<\/span><\/p>\n<\/div>\n<div id=\"sdfootnote16\">\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; font-size: 10pt;\" align=\"left\"><a href=\"#sdfootnote16anc\" name=\"sdfootnote16sym\">16<\/a> <span style=\"font-family: Gill Sans MT, serif;\">GR\u00c4FENBERG, Ernest, \u201cThe Role of Urethra in Female Orgasm.\u201d<\/span><\/p>\n<\/div>\n<div id=\"sdfootnote17\">\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; font-size: 10pt;\" align=\"left\"><a href=\"#sdfootnote17anc\" name=\"sdfootnote17sym\">17<\/a> <span style=\"font-family: Gill Sans MT, serif;\">Runels and Runnels, \u201cThe Clitoral Injection of IncobotulinumtoxinA for the Improvement of Arousal, Orgasm &amp; Sexual Satisfaction- A Specific Method and the Effects on Women.\u201d<\/span><\/p>\n<\/div>\n<div id=\"sdfootnote18\">\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; font-size: 10pt;\" align=\"left\"><a href=\"#sdfootnote18anc\" name=\"sdfootnote18sym\">18<\/a> <span style=\"font-family: Gill Sans MT, serif;\">Disphanurat et al., \u201cEfficacy of Botulinum Toxin A for Scar Prevention After Breast Augmentation\u201d; Lewandowski et al., \u201cOff-Label Use of Botulinum Toxin in Dermatology\u2014Current State of the Art\u201d; Fasano et al., \u201cThe Regenerative Effects of Botulinum Toxin A\u201d; Franz et al., \u201cBotulinum Toxin Conditioning Enhances Motor Axon Regeneration in Mouse and Human Preclinical Models\u201d; Aru et al., \u201cMicrocirculatory Effects of Botulinum Toxin A in the Rat\u201d; Duchen and Strich, \u201cTHE EFFECTS OF BOTULINUM TOXIN ON THE PATTERN OF INNERVATION OF SKELETAL MUSCLE IN THE MOUSE.\u201d<\/span><\/p>\n<\/div>\n<div id=\"sdfootnote19\">\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; font-size: 10pt;\" align=\"left\"><a href=\"#sdfootnote19anc\" name=\"sdfootnote19sym\">19<\/a> <span style=\"font-family: Gill Sans MT, serif;\">Decu, \u201c(Taoism) Chang, Stephen - The Tao of Sexology.\u201d<\/span><\/p>\n<\/div>\n<div id=\"sdfootnote20\">\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; font-size: 10pt;\" align=\"left\"><a href=\"#sdfootnote20anc\" name=\"sdfootnote20sym\">20<\/a> <span style=\"font-family: Gill Sans MT, serif;\">El-Shaer et al., \u201cIntra-Cavernous Injection of BOTOX\u00ae (50 and 100 Units) for Treatment of Vasculogenic Erectile Dysfunction\u201d; Giuliano et al., \u201cEffectiveness and Safety of Intracavernosal IncobotulinumtoxinA (Xeomin\u00ae) 100 U as an Add-on Therapy to Standard Pharmacological Treatment for Difficult-to-Treat Erectile Dysfunction.\u201d<\/span><\/p>\n<\/div>\n<div title=\"footer\">\n<table style=\"width: 100%; border-collapse: collapse;\" width=\"100%\" cellspacing=\"0\" cellpadding=\"7\">\n<tbody>\n<tr valign=\"top\">\n<td style=\"border: none; padding: 0in;\" width=\"83%\">\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.1in; direction: ltr; background: transparent;\" align=\"left\"><span style=\"color: #0563c1;\"><u><a href=\"https:\/\/runels.com\/\">Charles Runels, MD<\/a><\/u><\/span> 888-920-5311 <span style=\"color: #0563c1;\"><u><a href=\"https:\/\/cellularmedicineassociation.org\/\">CellularMedicineAssociation.org<\/a><\/u><\/span><\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">\n<\/div>\n<div style=\"border: 1px solid #ccc; background: #f6f6f6; padding: 14px 16px; margin: 1.8em 0 0 0; font-size: 0.82em; line-height: 1.5; border-radius: 4px; box-sizing: border-box;\">\n<p style=\"margin: 0 0 0.7em 0;\">This page is intended solely as professional education for licensed healthcare providers. It is not medical advice, not patient-directed advertising, and not an offer to treat any individual. Nothing here should be used by a member of the public to diagnose or treat any condition; patients should consult a qualified, licensed physician about their own care.<\/p>\n<p style=\"margin: 0 0 0.7em 0;\">The procedures and platelet-rich plasma (PRP) applications discussed are investigational and\/or off-label. They have not been evaluated or approved by the U.S. Food and Drug Administration (FDA) for the uses described, and the FDA has not approved PRP or these procedures to diagnose, treat, cure, or prevent any disease. References to the O-Shot\u00ae, P-Shot\u00ae (Priapus Shot\u00ae), Clitoxin\u00ae, Vampire Facial\u00ae, Vampire Facelift\u00ae, and other trademarked procedures describe training methods and clinical approaches; they do not imply FDA clearance or guaranteed outcomes.<\/p>\n<p style=\"margin: 0 0 0.7em 0;\">The content reflects a review of the published literature and the clinical opinions and experience of the author. Comparisons to FDA-approved drugs or surgical options (for example, references to a procedure as \u2018first-line\u2019) represent the author\u2019s interpretation of the cited studies and individual clinical judgment \u2014 not established medical consensus or proof of superiority, safety, or efficacy. Individual results vary, and no specific outcome is promised or guaranteed. Statements regarding the absence of reported adverse events reflect the limits of the available evidence base and should not be read as proof of zero risk.<\/p>\n<p style=\"margin: 0;\">Any clinical decision remains the sole responsibility of the treating licensed provider, who must exercise independent professional judgment, obtain appropriate informed consent, and comply with all applicable laws, regulations, and standards of care in their jurisdiction. The author and the Cellular Medicine Association assume no liability for actions taken based on this information.<\/p>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Journal Club with Pearls &amp; Marketing 2026.06.23 Cellular Medicine Association JCPM2026.06.23 The following is an edited transcript of the Journal Club with Pearls &amp; Marketing (JCPM) of June 23, 2026, with Charles Runels, MD. &gt;-&gt; The PDF of this live journal club can be seen here &lt;-&lt; Topics Covered PRP in Dermatology: Single-Spin, Double-Spin, and [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"jetpack_post_was_ever_published":false},"categories":[274,256],"tags":[283,311,2117,2119,2001,264,2116,594,2031,1823,89,2118,221,240,914,704,1809,827,113,2088,236,2124,2123,2122,520,506,666,40,30,65,2090,968,228,249,68,306,138,2121,2120,908,973,327,1949,886,846,1824,1073,166,2111,531,329],"class_list":["post-5153","post","type-post","status-publish","format-standard","hentry","category-clitoxin-r","category-pripaus-toxin-tm","tag-alopecia","tag-botulinum-toxin","tag-botulinum-toxin-dosing","tag-breast-cancer-survivors","tag-bremelanotide","tag-cellular-medicine-association","tag-clitoxin-dosing","tag-clitoxin","tag-daxxify","tag-double-spin-prp","tag-dyspareunia","tag-ejaculatory-orgasm","tag-erectile-dysfunction","tag-female-ejaculation","tag-female-orgasm","tag-female-sexual-dysfunction","tag-flibanserin","tag-fsfi","tag-gainswave","tag-informed-consent","tag-interstitial-cystitis","tag-journal-club-with-pearls-and-marketing","tag-masterson-study","tag-mesotherapy","tag-microneedling","tag-neovascularization","tag-neurogenesis","tag-o-shot","tag-off-label","tag-p-shot","tag-paraurethral-glands","tag-pde5-inhibitors","tag-peyronies-disease","tag-platelet-rich-plasma","tag-priapus-shot","tag-priapus-toxin","tag-prp","tag-prp-delivery-methods","tag-prp-dermatology","tag-prp-research","tag-regenerative-medicine","tag-ronald-virag","tag-saline-placebo","tag-sexual-medicine","tag-shockwave-therapy","tag-single-spin-prp","tag-skenes-glands","tag-urinary-incontinence","tag-vaginal-dryness","tag-xeomin","tag-xiaflex"],"jetpack_publicize_connections":[],"jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/p6W8NG-1l7","jetpack-related-posts":[{"id":5159,"url":"https:\/\/oshot.info\/members\/jcpm2026-07-07-priapus-toxin-p-shot-alopecia-areata-blindness-ozempic-vulva\/","url_meta":{"origin":5153,"position":0},"title":"JCPM2026.07.07 | Priapus Toxin\u00ae + P-Shot\u00ae | Alopecia Areata &#038; Blindness | Ozempic Vulva","author":"Charles Runels, MD","date":"July 8, 2026","format":false,"excerpt":"Journal Club with Pearls & Marketing 2026.07.07 Cellular Medicine Association JCPM2026.07.07 The following is an edited transcript of the Journal Club with Pearls & Marketing (JCPM) of July 7, 2026, with Charles Runels, MD. >-> The PDF of this live journal club can be seen here <-< Topics Covered Opening\u2026","rel":"","context":"In &quot;Priapus Toxin \u2122&quot;","block_context":{"text":"Priapus Toxin \u2122","link":"https:\/\/oshot.info\/members\/category\/pripaus-toxin-tm\/"},"img":{"alt_text":"","src":"data:image\/jpeg;base64,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","width":350,"height":200},"classes":[]},{"id":3380,"url":"https:\/\/oshot.info\/members\/jcpm2024-05-28-clitoxin-priapus-toxin-acne\/","url_meta":{"origin":5153,"position":1},"title":"JCPM2024.05.28 | Clitoxin\u00ae | Priapus Toxin\u00ae | Acne","author":"Charles Runels, MD","date":"June 18, 2024","format":false,"excerpt":"Journal Club with Pearls & Marketing 2024.05.28 \u00a0 \u00a0Cellular Medicine Association JCPM2024.05.28 The following is an edited transcript of the\u00a0Journal Club with Pearls & Marketing\u00a0(JCPM) of May 28, 2024, with Charles Runels, MD. >->\u00a0The pdf of the transcript of this live journal club can be downloaded for free here\u00a0<-< Topics\u2026","rel":"","context":"In &quot;acne&quot;","block_context":{"text":"acne","link":"https:\/\/oshot.info\/members\/category\/acne\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/cellularmedicineassociation.org\/wp-content\/uploads\/2024\/03\/image12-300x239.jpg?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":4368,"url":"https:\/\/oshot.info\/members\/jcpm2025-09-16-alopecia-overview-female-sexual-function-p-shot-post-radiation\/","url_meta":{"origin":5153,"position":2},"title":"JCPM2025.09.16 | Alopecia | Overview Female Sexual Function | P-Shot\u00ae Post Radiation","author":"Charles Runels, MD","date":"September 22, 2025","format":false,"excerpt":"Journal Club with Pearls & Marketing 2025.09.16 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0Cellular Medicine Association JCPM2025.09.16 The following is an edited transcript of the\u00a0Journal Club with Pearls & Marketing\u00a0(JCPM) of September 16, 2025, with Charles Runels, MD. \u00a0 >-> The PDF of this live journal club can\u2026","rel":"","context":"In &quot;alopeica&quot;","block_context":{"text":"alopeica","link":"https:\/\/oshot.info\/members\/category\/alopeica\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/cellularmedicineassociation.org\/wp-content\/uploads\/2025\/07\/image5-300x239.jpg?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":4996,"url":"https:\/\/oshot.info\/members\/jcpm2026-05-26-new-definitions-female-sexual-dysfunction\/","url_meta":{"origin":5153,"position":3},"title":"JCPM2026.05.26 | New Definitions (Female Sexual Dysfunction)","author":"Charles Runels, MD","date":"June 5, 2026","format":false,"excerpt":"Journal Club with Pearls & Marketing 2026.05.26 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0Cellular Medicine Association The following is an edited transcript of the Journal Club with Pearls & Marketing\u00a0(JCPM) of May 26, 2026, with Charles Runels, MD.\u00a0\u00a0 >-> The PDF transcript of this live journal club can\u2026","rel":"","context":"In &quot;female sexual dysfunction&quot;","block_context":{"text":"female sexual dysfunction","link":"https:\/\/oshot.info\/members\/category\/female-sexual-dysfunction\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/cellularmedicineassociation.org\/wp-content\/uploads\/2025\/07\/image5-300x239.jpg?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":4941,"url":"https:\/\/oshot.info\/members\/jcpm2026-04-21-o-shot-in-l-d-for-episiotomy-hair-and-skin-cancer-glp-1-and-bedroom\/","url_meta":{"origin":5153,"position":4},"title":"JCPM2026.04.21 | O-Shot\u00ae in L &#038; D for Episiotomy | Hair and Skin Cancer | GLP-1 and Bedroom","author":"Charles Runels, MD","date":"May 14, 2026","format":false,"excerpt":"The following is an edited transcript of the Journal Club with Pearls & Marketing\u00a0(JCPM) of April 21, 2026, with Charles Runels, MD.\u00a0\u00a0 -> The PDF of this live journal club can be seen here <-< =>The marketing kit for this journal club is here (pre-written emails)<= Topics Covered PRP Variability\u2026","rel":"","context":"In &quot;episiotomy&quot;","block_context":{"text":"episiotomy","link":"https:\/\/oshot.info\/members\/category\/episiotomy\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/cellularmedicineassociation.org\/wp-content\/uploads\/2025\/07\/image5-300x239.jpg?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":3557,"url":"https:\/\/oshot.info\/members\/jcpm2024-11-12-neck-wrinkles-prp-radiofrequency-microneeding-urination-with-ejaculation-in-a-man\/","url_meta":{"origin":5153,"position":5},"title":"JCPM2024.11.12 | Neck Wrinkles | PRP | Radiofrequency | Microneeding | Urination with Ejaculation in a Man","author":"Charles Runels, MD","date":"November 24, 2024","format":false,"excerpt":"Journal Club with Pearls & Marketing 2024.11.12 \u00a0 \u00a0Cellular Medicine Association JCPM2024.11.12 The following is an edited transcript of the\u00a0Journal Club with Pearls & Marketing\u00a0(JCPM) of Novemeber 12, 2024, with Charles Runels, MD. \u00a0 >-> The PDF file of the transcript of this journal club can be seen here <-<\u2026","rel":"","context":"In &quot;clitoris&quot;","block_context":{"text":"clitoris","link":"https:\/\/oshot.info\/members\/category\/clitoris\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/cellularmedicineassociation.org\/wp-content\/uploads\/2024\/03\/image12.jpg?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]}],"jetpack_likes_enabled":true,"jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/oshot.info\/members\/wp-json\/wp\/v2\/posts\/5153","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/oshot.info\/members\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/oshot.info\/members\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/oshot.info\/members\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/oshot.info\/members\/wp-json\/wp\/v2\/comments?post=5153"}],"version-history":[{"count":2,"href":"https:\/\/oshot.info\/members\/wp-json\/wp\/v2\/posts\/5153\/revisions"}],"predecessor-version":[{"id":5155,"href":"https:\/\/oshot.info\/members\/wp-json\/wp\/v2\/posts\/5153\/revisions\/5155"}],"wp:attachment":[{"href":"https:\/\/oshot.info\/members\/wp-json\/wp\/v2\/media?parent=5153"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/oshot.info\/members\/wp-json\/wp\/v2\/categories?post=5153"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/oshot.info\/members\/wp-json\/wp\/v2\/tags?post=5153"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}